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1Introduction:
Siddha system of medicine is the divine medicine, which was founded by
siddhars, it is considered to be one of the ancient traditional medicine in the world,
Siddha system of medicine is prevalant before tholkappiam it was proved by some
of the literary evidence.
Panchabootham and uyir vayus are responsible for the organsiation of this body
and universe from the microcosam and macrocosam. When the equilibrium of this
panchabootham and uyir vayus are distrubed various disease are formed in our body.
 Medicine is not merely a science but an art as well. This science is fundamently
important to man’s well being and survival.
The present concept of poverty and malnutrition is a major cause for disease.
In siddha three vital humours are major role to maintain the body. The deranged
humours (or) Altered humours can produce the diseses. In this view thiruvalluvar in
thirukural says,
“IAÂ‹ °¬øJÂ‹ «ï£Œ ªêŒ»‹ Ë«ô£˜
õOºîô£ â‡Eò Í¡Á” ÜFè£ó‹&941
Derangements of these three thathus causes disease. In developing countries
like India “pandu noi” is more prevalant.
The symptoms of the disease can  similarly correlate in Modern science as  Iron
defeciency anaemia. The word aneamia actually means “Lack of blood” in greek. This
disease affects 1 in 5 people in the developed world. It affects the person who suffer
from malnutrition and chronic diseases.
2According to siddha concept, it is caused due to disturbances in normal blood.
Which is one of the seven humour of the body (Seven UdalThathukkal).
“Yugimuni” the great siddhar quotes seven humour as follows.
Yugimunivar clearly mentioned that blood plays an vital role in forming
seven humours.
“ªê¡¬ñ ñ£˜„ gó‰  ªî£‡ÈŸÁøƒ° ôñ£‹
 ªêŒA¡ø õóõ˜èœ ¬èò£«ôî£¡
î¡ùñ£‹ óê ñóˆîñ£ ƒèêº«ñ¬î
î¬ê ñ„¬êªò£´ ²‚ô‰î£ «î£ö£A
à‡ñ£ º¼ ªõ‡µëêgóñ£A
àJ˜ ê†¬ì óê…«ê˜ˆ¶ «ó£ññ£A
õ¡ùñ£‹ õ£î Hˆî «ê†ðñ£A
õ¼A¡ø ê†ìˆFQì õ‡¬ñ «è«÷.”
- -ÎA ¬õˆFò C‰î£ñE
The seven humour are formed from panchaboothas by pancheekaranam.This
concept was quote by “Thirumoolar in Thirumandiram as,
“Þóî‹ àFó‹ Þ¬ø„C «î£™ «ñ¬î
ñ¼Mò õˆF õ£°‹ ªð£´ñ„¬ê
ðóMò ²‚Aô‹ ð£ö£‹ àð£F
à¼õñô£½ì¡ å¡ªøùô£«ñ” - - F¼ñ‰Fó‹ - 2086
3Vathapandu affects many crores of people in the world . About 20% of world
population  is prevalent to Anaemia. Environmental pollution,Lack of well balanced
diet , infections and poisonous substance are the promotors of this disease.
Though this disease can be diagonsed and treated easily.If untreated in advance
stage it may affects important vital organs like Heart, kidney, digestive system.
Untreated pandu noi may leads to sobai (oedema) and kamalai(Jaundice)
So, I have selected herbal formulation “Karisalankanni chooranam” to asses
clinical and therapeutic effect in the management of Vatha Pandu noi.
Both the good diet and the better absorption brings the best efficacy.This
drug contains Karisalankanni which is rich in Iron,mookirattai which acts as an
Liver tonic,  Kadukkai, Nellikai, Thandrikai which is known as “Triphala” is added
which helps for the absorption of iron and various other drugs are added  are more
efficient in curing this disease. This work present with prestige about the various
clinical findings clinical assessment,various studies in the treatement of vathapandu.
4AIMS AND OBJECTIVES
The Aim of this works is to make an observation of aetiology, pathogenesis,
clincial features, treatment, prognosis of vatha pandu noi.
For the purpose of diagnosis the eight types of  clinical investigation of siddha
medicine (Ennvagai thervugal) and relavant modern diagnostic methods are also to
be adopted.
The selection of cases is to be made from the OPD-Department of Pothu
Maruthuvam , Government Siddha Medical  College and hospitals, Palayamkottai.
The patients are given with “Karaisalankanni chooranam”.
The dynamic approach deals very much in detail with the work done with devotion
and dedication to bring out the following objectives are,
1. To collect various siddha literatures dealing with nomenclature, defintion,
aetiology,classification, signs and symptoms, Naadi, diagnosis, diet, prognosis,
complications of “Vatha Pandu Noi” in Siddha system of medicine.
2. To know the extent to which the correlation of Aetiology,classification, signs
and symptoms of Pandu Noi in Siddha medicine as well as modern medicine.
3. To expose the efficacy of Siddhar’s diagnostic principles. (Envagai Thervugal)
54. To have some idea about the disease like incidence, prevalance and surveilance
of the disease.
5. To know the clinical and therapeutic efficacy of the trial medicine.
6. Biochemical, pharmocological studies which have been ruled out to find the
potency and free toxic effect of the trial drug.
7. To evaluate the safety profile drug of the trial medicine Karisalankanni
Chooranam.
6REVIEW OF LITERATURE
Siddha Literature
Siddha system is said to have orginated from lord siva. Agasthiyar was the
first disciple of lord siva. He was the pioneer to propogate this siddha system of
medicine.
The siddha system of medicine is based on the tridhosa theory. According to
which the human system is mediated by three vitiatling elements (or) thathus which
is the functional units of living beings namely vatham, pitham and kabam.
Diseases are produced by disequilibrium of this three vitaling elements which
may be due to various causes like dietetic regimen, life style pattern and ecological
imbalance etc..
The diseases “Vatha Pandu” has its historical importances. The word “Pandu”
has been derived from the great hindu epic “MAHABHARATHAM” where the
father of five heros “PANCHA PANDAVAR” is “Pandu”. It is said this man when
born was very pale and anaemic and this condition was named after him as “Pandu”.
SYNONYMS OF PANDU
Vemai Noi, velluppu Noi, ven pandam.
7IYAL (Definition):
Pandu is the diseases of raktha thathu charactertics by pallor of skin,nail
beds and conjuction. The great siddhar Agasthiyar define pandu as,
“²Nõ£°‰î «îèñŠð£ è£íˆî¶ õ‰î£Œ
õŸPM´ ñ¡ùõ£ê™ «è†A™
ðNè£ó˜ ºèˆFQ™ ºNò£˜ «ð£«ô ð£‡ìªñô£‹
ªõÂ‚è®ˆî¶ óˆî‹”
& ÜèˆFò˜¬õˆFò è£Mò‹.
“«îèˆF™ Þóˆî‹ õŸP
béè£ù Mˆî «ï£Œ è£µñŠð£”
- & ÜèˆFò˜°íõ£èì‹.
The blood is subjected to various researches from ancient days. It was also
believed  that the man’s life is decided by blood in those days. Blood acts as mirror
that reflects any pathological changes in the body.
According to pattinathar these are crores of uyir anukkal in blood. He says,
“«ñMò ¹¡ñJ˜ˆ ªî£¬è«ò Ü‹ñJ˜
ð£Mò «î£L¡ ðóŠ«ð£ «î£Q¬ìŠ
¹èL†´Š ªð£Fˆî ¹‡«í£ ¹‡E¬ì
áÁ‹ àFóŠ ¹ù«ô£ ÃÁªêŒ¶
Þ¬ìJ¬ì GŸ°‹ â½‹«ð£ â½‹H¬ì
º¬ìªè¿ Í¬÷ M¿«î£ õ¿õ¿ˆ¶
8àœO¬ì ªò£º°‹ õ¿‹«ð£ ªñ™ô G¡Á
áÁ‹ ¹¿M¡ å¿é«è£ cK¬ì...”
& ð†®ùˆî£˜
(F¼M¬ìñ¼É˜ º‹ñE‚«è£¬õ)
According to siddhars. As the digestion takes place in the body Rasathathu is
formed on the very first day. On the second day Raktham is formed it is followed by
the formation of mamisam,kozhuppu,enbu,moolai, sukkilam or suronitham on
respective days that is on 3rd, 4th, 5th, 6th and 7th days respectively.This is called as
udalthathukal.It is to be noted that the nutrients absorbed after digestion are responsible
for the metabolic functions and the formution of blood.
NOI VARUM VAZHI:(Aetiology)
According to “YUGI MUNIVAR ”. in yugivaithiya chinthamani clearly mentioned
the etiopathogenises of the diseases.
“ÜP‰¶«ñ àŸðˆF ªê£™ô‚ «è÷£Œ
ÜFê£ó ñ÷I÷A ªò‰«ïó‰î£¡
HP‰¶«ñ ¹O»Š¹ ªð¼ˆî£½‹
ªðˆîñ£ ñ‚AQJL¼‰îô£½‹
IP‰¶«ñ î£‹Ìô Iè Ü¼‰îô£½‹
eP«ò ñ¶‚è¬÷ˆ î£¡ ¹Cˆî£½‹
ðP‰¶«ñ ðè™ GˆF¬ó«ò ªêŒîô£½‹
ð£‡´ õ‰¶ ð£K½œ«÷£˜ ð´‹ ð£ì£«ñ.
9ð£ì£ù ð…²î¬ù F¼® «ù£˜‚°‹
ð£ƒè£ù Cõ ¶J¬ô îˆ F¼® «ù£˜‚°‹
ñ£ì£ù ð²õ¬îŠ ð†®Qò£è
¬õ‚A¡«ø£˜ ñ¬øõNJ™ ïì‰Fð£˜
è£ì£ù õ£óEòˆ îQŸ ðPˆ¶‚
è´õ¬îèœ ªêŒA¡«ø£˜èœ è‡è£í£î
«è£ì£ù ðNªê£™L‚°®ªè¼‚°‹
ªè£´‹ ð£M ð£‡´Mù£Ÿ °F ªè£œõ£«ó”
& ÎA¬õˆFò C‰î£ñE
Yugi muni says that wrong life style excessive intake of food stuffs with salt and
sour taste, staying for long time in hot climate. excessive intake of pan and alchol ,
sleep in the daytime leads in pandu.
2. In Agathiyar vaidhyam - 80
Pandu is considered as one among the kanma noi.
“°J™õ£Œ °wì‹ êòƒ°¡ñ cKN¾ ²óƒAó£E
có¬ìŠ¹ ð£‡´ Íôõ£Œ¾
è¡ñõ£» õ¼ƒè‡E™ °‰î£Œ è®ù‰ îêõ£Œ¾
è£íõ£è º¡ªêŒî àJ˜èÀ‹ M¬ùî£«ù”.
In Agasthiar paripooram-400.
“ªê™ô£î è®Mìƒèœ °¡ñ‹ ð£‡´
¶ò˜ bó£‚ è¡ñM¬ù ªêŒî ð£õ‹
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â™«ô£¼‹ ï¬è‚è à´‹ªð´ˆî ð£M
Þ¡ùº‡´ Mðóñ£Œ àôAŸ«è«÷”.
è®Mìƒèœ - Hemolysis due to toxins
°¡ñ‹ - Acid peptic disease
è¡ñM¬ù-Abnormal morphological changes in RBC(Genetic Disorder).
In Agasthiyar Gunavagavagadam:
“ªè£œ÷ì£ Üð‚°õ «ð£êùˆFù£½‹
°®ªè´ˆî ªð¼‹ð£´ Aó£Eò£½‹
èœ÷ì£ è¼ŠðˆF¡ Aó£Eò£½‹
èùñ£ù óˆîˆF¡ «ð£‚Aù£½‹
Üœ÷ì£ ÜFò£ñ èõùˆî£½‹
Ü÷õŸø Mê£ó‰î£ù¬ì»‹ «ð£¶‹
ªîœ÷«õ «îèˆF™ óˆî‹ ªè†®
ªîOõ£ù ð£‡ì¶ ¾ º‡ì£‹ ð£«ó”.
Mal nutrition
Dysfunctional utrine bleeding
Ulcerative colitis
Bleeding disorders.
According to agathiyar Improperly cooked food, food habits, Imbalanced diet,
menorrhagia in females, chronic Diarrhoea, karupa kirani, blood loss due to various
aetiology, stress and strains are the causes of pandu.
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In Thanvanthiri vaidhyam:
“F¼‰F´‹ ð£‡´ «ó£è… «ê˜‰F´‹ °íˆ¬î‚ «è÷£Œ
Þ¼‰F´‹ õ£î Hˆî C«ôŸðù I¬õî£¡ ñ£Á‹
ðK‰¶ î£ªù£¡«ø£ ªì£¡Á ªð£¼‰¶õî£½ ñ‡«í£
ì¼‰¶õî£½‹ ð£‡´ Ü¬í‰F´ ªñ¡ùô£«ñ
ÝAò Íô‰î¡Q ô¬í‰î¾†ìíˆFù£½‰
«îè «ð£û¬í»œ÷£˜‚°ˆ îKˆFó… «ê˜îô£½‹
«õèñ£‰ FK«î£-ûéèœ IëC«ò ð£‡´õ£«ñ.”
Imbalance between three thathu, excessive heat, pica (eating of sand), accumulation
due to abana, sorrow, psychological factors may lead to vitation of three thathus
and cause pandu.
Due to worm Infestations:
“õò™îQ«ô Ìï£è ñ‡¬íˆ î£«ù
õ¼‰Fò¶ ¹ˆ¶ «ð£ô õ‰¬îò£°‹
ðJ™ ªñ£Nf˜ «îèˆF™ A¼Iî£«ù”
& °¼ï£®
Pathological loss of  blood may occur due to various cause one among them  is
worm infestation which leads to Iron deficiency anaemia.
In Agasthiyar Gunavagadam:
“ï£ªñ£¡Á ªê£™½A«ø£‹ ð£‡´ õ‰î
ïôñ£ù è¼ññ¶ ªê£™ô‚ «èÀ
î£ªñ¡ø î£Œî‰¬î ñù‹«ï£è ªêŒî™
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îóEîQ ½œ÷õ˜‚°‹ Ü¡«ð ªê£™ô
ô£ªñ¡ø M¼ŠðNˆî™ ªêM ²õ£ê
ñŸÁ‹ ªð£Œªê£™ô£ƒ è£ó…ªêŒî™
«õªñ¡ø è¼ññ¶ Hˆî «ñP
ªõÁˆîîì£ ªõŠ¹ I…C‚ ¬èè£ô«ô£Œ”
Agasthiyar say that Irresponsiblity and disobediance to parents, speaking lie, getting
anger on other’s stimulates pitha dhosam which results in pandu Noi.
In Therayar mahakarisal:
“õ£î ð£‡´ «ï£«ò î£Â‹ õ‰F´‹ ðKê«è÷£Œ
ê£î‹ cg„¬ê »ŸÁˆ î¡Qøé è¼F õ£®„
Å¶«ê˜ ªê£¼ð º‡ì£Œ„ ²«ó£Eî‹ õŸøõŸø
Ýîóõ£ñ¬ùˆ¶‹ ÜFêò ñ£¼-------ƒ è‡ìñ£Œ”
“ Theryar vagadam” Denotes causative factor of  pandu as
“è¼Fò eQ¡ ºœÀ‹ èôˆ¶I ªïŒJ¡
ñ¼Mò â½‹¹------ƒ è™½‹ ñƒ¬èò˜ ñ¼‰F´‹
ð¼Aò ðö…«ê£Ÿø£½‹ ðöñô Gø¬èò£½‹
ñ¼Aò ñJ˜è÷£½‹ õ‰F´‹ «ï£Jî£«ñ
¹øõ¬ó »‡¬è ò£½‹ «ð£è c¼‡¬èò£½‹
²¼÷«õ ºì‚A‚ ªè£‡´ ºø‚Aì‚ ¬èò£½‹
ñ¼÷«õ «ñ´î¡Q™ ñùºø‚ Aì‚¬èò£½‹
ªð¼è ªõ‡ð£®Jù£½‹ Hø‚è «ï£ªò¡Áè£«í”
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Intake of  fish bones, paddy brane, small and store old rice, hairs which can produce
pandu secondly severe constipation, polluted water, sleeping in abnormal posture
causes veluppu Noi.
Noi enn (Classification):
According to yugimunivar Pandu Noi is classified into 5 types. This was seen in
his quote.
“Ãø«õ ð£‡´MìŠ ªðò¬ó‚ «è÷£Œ
°PŠð£è ¬õ‰¶ Mîñ£°‹ ð£¼
õ£ó«õ õ£îñ£‹ ð£‡® «ù£´
ñ£˜‚èñ£‹ HˆîˆF¡ ð£‡´ î£Â‹
«îø«õ C«ô†´ññ£‹ ð£‡´ î£Â‹
FK«î£ìŠ ð£‡«ì£´ Mìð£‡ ì£°‹”
Vathapandu
Pithapandu
Kaphapandu
Mukkutra pandu
Vishapandu
are 5 types of pandu Noi according to yugi muni.
Thanvanthiri classification:
Thanvathiri classifies pandu Noi into 7 types they are,
“ðJˆFò ð£‡´ õ£î ð£‡´«õ C«ôˆ¶ñ ð£‡´
MòˆFK «î£û ð£‡´ ªõÀ‹ Hˆî C«ôˆ¶õ ð£‡´
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ðJˆFò õ£î ð£‡´ ðè˜ê‰G õ£î ð£‡´
ïòŠ¹Á‹ ð£‡´ «õN¡ °íˆ¬î ï£¡ïM½ ½Ÿ«ø¡”
Vatha pandu
Pitha pandu
Kapapandu
Mukkuta pandu
Pithavatha pandu
Pithakapha  pandu
Sannipatha pandu
Agasthiyar classification:
Pandu Noi was classified into 5 types by agasthiyar
“ð£óì£ ð£‡´õ¬è ªê£™ô‚ «è÷£Œ
ðKõ£ù ð£‡ì¶ î£ùë «êò£°‹
õ£óì£ õ£îHˆî‹ Yî ð£‡´
õ¬èò£ù Mìð£‡´ I¼ˆFè£ ð£‡´”
                                         & ÜèˆFò˜ °íõ£èì‹
Vatha pandu
Pitha pandu
Kapha pandu
Visha pandu
Miruthika pandu
Classification of pandu in various siddha literature are given below.
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In Jeeva Rakshamirtham:
Vathapandu
Pithapandu
Kapha pandu
Mukkutra pandu
Nanju pandu
Mirthikapuktha pandu
Alimuga pandu
In Sigitcharatna deepam:
Vatha pandu,Pitha pandu, kapha pandu, thiridhosa pandu, vishapandu
T.V Sambasivam pillai dictionary
Vathapandu
Pithapandu
Kapha pandu
Mukkutra pandu
Oothu pandu
Neer pandu
Eri pandu
Visha pandu
Roga nirnaya saram:
vathapandu
pithapandu
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Kapha pandu
Mukkutra pandu
Visha pandu
Anubava vaidhya devaragasiyam:
Vathapandu
Pithapandu
Kapha pandu
Mukkutra pandu
Nanju pandu
Mirthika puktha pandu
Most of the siddha litrature clearly mentioned the disease based upon
kutrangal.
Noi Kurikunangal (clinical features):
Patients experiences the symptoms like fatigueness, difficult in breathing on
exertion, blurred vision, giddiness, palpitation, pallor of skin,nail beds, conjuctiva,
headache,anorexia.
According to yugi munivar:
“ªè£œ÷«õ õ£î ð£‡´ «ó£èé«è÷£Œ
°ì™Hó†® ò®õJÁ î£¡õL‚°‹
îœ÷«õ î£èªñ£´ ðC»I™¬ô
îöô£ù ²ó²óŠð£èˆ î£Â‹
ïœ÷«õ ïó‹ªð™ô£‹ èÁŠ¹ñ£°‹
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ï´‚èªô£´ è‡CõŠ¹ ñôð‰î‰î£¡
M‡÷«õ î¬ôõL‚°‹«ñQiƒ°‹
ªõÀŠð£°‹ õ£îˆF¡ ð£‡´õ«ñ”.
Abdominal discomfort, decreased appetite and intake of water, dryness of skin,
tremor redness of eyes, constipation, headache, generalised oedema, pallor of skin
are the clinical features of “vatha pandu”.
According to agasthiyar gunavagadam:
“à‡ì£°‹ «õ¬÷ î¡Q™ «îè «ï˜¬ñ
àÁFò£Œ„ ªê£™½A«ø¡ ï¡ø£Œ ð£¼
°‡ì£ù ºè‹ è‡èœ àî´ ï£‚°
°PŠð£ù õ£Œ«õ°‹ «îèºŸÁ‹
ªõ‡ì£è «õ»ô˜‰¶ ªõ‡¬ñò£A
Mó™ ïèƒèœ º¿õF½‹ óˆî‹ õŸP
è‡ì£ è£™èœ î£¡ îE‰¶ GŸ°‹
è¼õ£ù ï£®ò¶ ªñ¶õ£Œ «ð£«ñ” (23)
“«ð£«ñî£¡ bðùƒèœ ñ†´Šð†´
ªð£Lõ£ù è‡MNèœ ªð¼ˆ¶ˆ «î£¡Á‹
Ý«ñî£¡ ÜêF»ñ£ò£êƒè‡´
Üõ˜ ï¬ì»‹ î÷˜‰¶ ªð¼Í„²‚è‡´
Í«ñî£¡ Í˜„¬ê»ì¡ ñ£˜ ¶®ˆ¶
º®õ£ù èµ‚è£L™ i‚èº‡ì£Œ
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É«ñî£Q¼îòˆF¡ õîù‰ î¡QŸ
¶¼ˆF Gè˜ êˆîñ¶ «è†°‹ ð£«ó” (24)
-& ÜèˆFò˜ °íõ£èì‹.
Pallor of skin, conjuctiva, tongue, lips and nail beds, dryness of skin, loss of appetite
triedness, giddiness, breathlessness on exertion, palpitation,fatigueness, pedel
oedema, Increase heart rate are the main symptoms of this disease.
Thanvanthiri vaithiyam:
“Ýù è‡ ñôêôƒèœ ÜE ïèƒ èÁŠðî£°‹
î£èñ£ ñƒè ªñƒ°‰î î®ò® ð´¬è«ð£«ô
eùñ£Œ ï´‚èº‡ì£ I¬ê‰î¶˜ ðôºº‡ì£
ñ£ùc˜ õ£îð£‡´ ªõ¡ùõ°‚èô£«ñ”
-& î¡õ‰FK ¬õˆFò‹ 500
Black colouration of eyes, faeces, nails,urine, pain all over the body, tremor,
fatigueness, are the symptoms of vathapandu Noi.
Anubava vaidhya deva ragasiyam:
Discolouration of nail, eye, tremor, generalised body pain, dropsy, fatigueness
dryness of skin,dullness of face, abdominal pain,loss of apetite and thirst.
Jeeva rakshamirtham:
Vatha pandu is characterised by generalised body pain,nail beds,faeces and
urine are dark in colour constipation,headache, dull pain over chest and abdomen
,loss of apetite.
19
Vaidhya sara sangiraham:
Swelling and pain over the lower extrimities pallor of skin, lips, eyes,tongue
,urine, dryness of skin, flatulent of abdomen are the feature of vatha pandu.
Roga nirnaya saram:
Pain all over the body,tremor, discoloration of nail, conjuctiva, headache
dryness of skin are the symptoms of vatha pandu.
Mukkutra verupadugal (Patholgy of vatha pandu):
Our siddha is based upon thirdhosic theory due to extrinsic and intrinsic
factor the pitham in the body gets altered and the digestion is affected.In the blood
stream the  ranjagam which is the branch of pitha which gives colour to the blood is
unable to entertain these ill digested and improperly assimilated nutrients with raktha
thathu these defect manifest in the haemopoisis and produce anaemia with the
symptoms of pallor of tongue, conjuctiva, nail beds and skin.
The detoriation of kapha thathu with pitham and vatham produces oedema
these altered dhosha’s finaly alter the normal structure and function of seven thathus
which are called Udal thathukal.
Piniyari muraimai (Diagnosis)
Piniyari muraimai is the method of diagonsis the disease affecting the man
It is based upon three main principles they are.
Poriyal arithal - Physical examination, Perception
Pulanal arithal - On examination
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Vinathal - Symptoms and Signs
Pori is considered as the five sense of perception namely nose, tongue, eye,
skin, and ear.  While pulan are five objects of senses they are smell, taste, sight,
sensation and sound. Vinathal is obtaining information regarding the history of the
disease, its clinical features etc... From the patient or his immediate relatives who
are taking care of him when the patient is a position to speak or the patient is a child.
The above principles corresponds to the methodology inspection, palpation
and  interrogation of modern medicine.
Alavai is a parameter through which one can assess the properties, merits
and demerits of the things using the  five senses as instruments.
It is very much useful in diagnosing vatha pandu as follows.
Kandal(observation):
By observing the pallor of skin,conjuctiva, nail beds, mucus membrane of
lips and tongues.
Karuthal (Inference):
Patients compliants of fatigueness, palpitation, breathlessness on exertion
give the clue to the physician in diagnosis  of pandu Noi.
Urai(Authority):
In addition to the above manifestation the Naadi shows kabam,kabavatham
kaphapitham and vatha kapham which confirms in the diagnosis of vatha pandu.
these are quoted in.
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“è‡ì£«ò£ C«ôŸðùˆF™ õ£îï£®
èô‰F´A™ õJÁ ªð£¼ñ™ èùˆî i‚è‹
à‡ì£«ò£ æƒè£ó… êˆF M‚è™
àÁFó†¬ê õ£Œ¾ õLê‰G «î£ì‹
M‡ì£«ò£ J¬÷ŠH¼ñ™ «ê£¬ð ð£‡´”
& êîè ï£® Ë™
“î£ùºœ÷ «êˆ¶ ñ‰î£Q÷A™ ªõŠ¹
êòI¬÷J¼ñ™ ñ‰î£ó è£ê‹
ßùºÁ…ê‰F Mì«î£ì‹ M‚è™
J¼‰ «ó£èƒèóŠð£¡ Móí «î£ì‹
ñ£ù¬ùf˜ Å¬ô Fóœ Mò£F i‚è‹
õ¼…êˆF ²õ£ê‹ ªï…ê¬ìŠ¹ É‚è‹
ãùºÁƒ è£ñ£¬ô ð£‡´ «ê£¬ð
ã¿²óƒèœ  ðô¶‚è‹ Mìº‡ì£«ñ”
& êîè ï£®
“Þìñ£ù «êˆ¶ñˆF™ Hˆîï£®
â¿ˆîµA™ Mìºì«ù i‚èº‡ì£‹
Fìñ£ù °O˜ è£Œ„ê™ ñ…êœ «ï£¾ˆ
«îèˆF½¬÷„êh¬÷Š H¼ñ™ õ£‰F
Mìñ£ù ªï…ê¬ìŠ¹ ²õ£ê‹ M‚è™
ªõ°²óº‹ ï£õø†C ð£‡´ «ó£è‹
Üìñ£ù °õ¬÷ óˆî ñFê£óˆî£¡
ÜµA ªõ° ðô «ï£Œ‚°ˆ îìƒè‡ì£«ò”.
& êîè ï£®
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“õ£îˆF™ «êˆ¶ñ ñ£A™ õL«ò£´ i‚èº‡ì£°‹
«ðFˆ¶ˆ î¬ôJ®ˆ¶Š HíƒAò °íƒèœ
b¶ŸÁ ªñŒªõÀˆ¶ˆ Fìºìù êù… ªê™ô£
«ðFˆ¶ ï£¾ «ð²‹ ªð¼è«õ i‚è º‡ì£‹”
&ÜèˆFò˜ ï£®
Enn vagai thervugal:
Enn vagai thervugal namely naadi, sparisam,naa, niram mozhi, vizhi, malam,
moothiram are called as the tools in the diagnosis of disease. It is called “Maruthvan
Ayutham”.
Therayar quoted this as
“ï£® ðKê‹ ï£ Gø‹ ªñ£N MN
ñô‹ ÍˆF¬ó I¬õ ñ¼ˆ¶õó£»î‹
ªñŒ°P Gø‹ ªî£Q MN ï£ Þ¼‹ðô‹
¬è‚°P”.
& «î¬óò˜
Ennvagai thervugal was mentioned in agathiyar vaidhya vallathi -600 as
“ªî£‚èÖŸÁ Ü†ìMîŠ  ðg†¬ê î¡¬ù
¶ô‚èºÁ‹ ð‡®î«ó ªîOõî£èŠ
ð°‚èKò ï£®¬ò c H®ˆ¶Š ð£¼
ðè˜A¡ø õ£˜ˆ¬î¬òŠ ð£˜ ï£¬õŠð£¼
õ°‚èKò «îèªñùˆ ªî£†´Šð£¼
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õ÷ñ£ù êgóˆF¡ Gøˆ¬îŠ ð£¼
êA‚èKò ñôˆ¬îŠð£˜ êôˆ¬îŠ ð£¼
ê£˜‰î MNî¬ùŠ ð£˜ˆ¶ ªîOõ£Œ‚ è£«í”.
Agasthiar vaithiya vallathi 600 mentioned the Envagai thervugal as attavitha
paritchai.
“ï£®ò£™ º¡«ù£˜ ªê£¡ù ïŸ°P °íƒè÷£½‹
c®ò MNòù£½‹ G¡ø ï£‚ °PŠHù£½‹
õ£®ò «ñQò£½‹ ñô«ñ£´ cKù£½‹
Å®ò Mò£F î¡¬ù ²è‹ ªðø õP‰¶ ªê£™«ô”.
-&ÜèˆFò˜ ï£®.
Thiruvalluvar says,
“«ï£Œ ï£® «ï£Œ ºî™ ï£® Ü¶ îE‚°‹
 õ£Œ ï£® õ£ŒŠð„ ªêò™”
Naadi:
Naadi is the vitiating element of the body which are vatham,pitham and
kapham. Examination of naadi has been recognised as one of the principle means of
diagnosis and prognosis of the disease.
Naadi is felt at the lower end of radius, Three fingers that is index, middle
and ring finger is placed on the radius which shows vatham, pitham,kapham naadi
respectively.Changes in the thiridhosa are felt in naadi.
Edakalai +Abanan   -> vatham
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Pinkalai + Piranan  -> pitham
suzhumunai + samanan    -> kapham
the ratio of vatham,pitham, kapham is 1:1/2:1/4 respectively.
In females naadi is felt best on left side and for males on right side.
Naadi is considered as the best tool in the diagnosis of vatha pandu.
In vatha pandu the following types of naadi are seen.
Kapham,kapha vatham, kapha pitham, vatha kapham.
In anaemia naadi is low volume, feeble pulse.
Sparisam (palpitation):
Temperature of the skin, any abnormal growth, hypersensitiveness, dryness
of skin, ulcers, oedema are seen in sparisam.
In vatha pandu noi the sparisam is warm.
Naa(Tongue):
The colour changes according to vatham, pitham,kapham, mukkutram are
dryness or wet, coated tongue or not, excessive salivation, redness, ulcer, pallor,
yellowish discolouration, neoplastic growth, condition of teeth, its colour, condition
of the gums, loss of taste, appreciation speech, deviation of the mouth  angle
movements of the tongue are seen.
In vatha pandu noi tongue was pallor moist and glossy, sense of taste would be
altered.
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Niram(colour of the skin):
Colour indicating vatham,pitham,kapham and thiridhosa are pallor,yellow
discolouration, redness of the skin and bluish discolouration. In vatha pandu the colour
of the skin,tongue,nail beds and conjuctiva are pallor.
Mozhi(voice):
Clarity of speech or any disturbances, loud voice, slurring,crying,talk induced
by hallucination, breathlessness can be made out.
In vatha pandu the speech is in  diminshed voice, breathlessness may occur.
Vizhi(eyes):
Pallor, excessive lacrimation, visual disturbances, suborbital oedema of the
eyes are ruled out.
In vatha pandu the conjuctiva is observed which are pallor in this condition.
Malam(faeces):
Quantity, semisolid,colour, odour, froth abnormal consistency , frequency,
constipation are observed.
In vatham -ñô‚è†´,è¼ˆîñô‹
Hˆî‹ & CÁˆ¶ à†íˆ¶ì¡ ªê‹¬ñGø‹
èð‹ & Yîñ£J¼‚°‹
ªî£‰î‹ & â‰î Gøº‹ Þ¼‚èô£‹
This was quoted as,
è¼ˆî ñôð‰î ñôƒ è£ô£´‹ Iˆî‹
CÁˆî º†®í‹ ªê‹¬ñ «ê¼‹ ªð£Áˆªî£¼‚è£™
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Yîñô‰ F™¬ô»ñ£‹ «ê˜‰î ðô «ó£Aò£‹
eîðô‹ â‡Eøº «ñ.
&ÜèˆFò˜ ¬õˆFò C‰î£ñE ªõ‡ð£ 400
In vatha pandu noi constipation is usually seen.
Moothiram(urine):
In Agasthiyar vaithiya chinthamani the colour of urine was quoted.
“õ£î«ó£ è‹ ªîO‰î£¡ ñ…êOˆî£¡ ñŸ¬øò¶
YîÂ¬óˆ î£˜ðôõ£‹ «ê˜‰î «ï£Œ &«è£îèô£
ÍˆFóˆF¡ à‡¬ñ ªñ£N‰«î£‹ Þ¬ê ªê£™ô£‹
ï£ˆFóˆF¡ àœ÷õ¬è ï£‹”.
-&ÜèˆFò˜ ¬õˆFò C‰î£ñE ªõ‡ð£ 400
 In õ£î‹&c˜ ªîO‰F¼‚°‹
Hˆî‹&ñ…êœ Gø‹
èð‹&Yî‹ èô‰¶ è£íŠð´‹
ªî£‰î‹&Þ¬õ èô‰F¼‚°‹
Quantity, colour,odour, frothy,frequency,deposits,presence of abnormal constituents
such as sugar, albumin etc... are seen.
It contains two phase in diagnosing they are
- Neerkuri (colour of the urine)
- Neikuri (oil examination)
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Collection of urine:
“Ü¼‰¶ ñ£Póîº‹ ÜM«ó£îñî£Œ
Üçè™ Üô˜î™ Üè£ô×¡ îM˜‰îöŸ
°Ÿøùõ¼‰F àøƒA ¬õè¬ø
Ý®‚èôêˆ î£M«ò è£¶ªðŒ
ªî£¼ºÃ˜ˆî‚ è¬ô‚°† ð´ cK¡
Gø‚°P ªïŒ‚°P G¼Iˆî™ èì«ù.”
The patient must take well cooked food, propotionate to the degree of his appetite at
apporopriate time on the previous day.After having sleep at night the urine is collected
on the early morning of the next day in a glass container and to be examined within
hours.
Neerkuri:
“õ‰î c˜‚èK â¬ì ñí‹ ¸¬ó â…êªô¡
¬ø‰Fò½÷õ¬õ ò¬ø°¶ º¬ø«ò”
In neerkuri colour, odour, specific gravity, forthy, quantity, deposits were observed.
Colour:
Yellow,red,green, black, crystal, smoky, copper.
Manam(Smell):
Pleasant, foul smelling, honey, fruit and flesh smell.
Nurai(Forthy):
Forth with or without colouration.
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Enjal(Quantity):
Amount of urine expelled and any deposits in urine are observed.
Frequency:
Increased or decreased frequency, dribbling, incontinence of urine.
And the specfic gravity of urine are observed.
Neikuri:
“Gø‚°P‚ °¬óˆî G¼ñ£ù cKŸ
Cø‚è ªõ‡ªí«ò£˜ CÁ ¶O ï´M´ˆ
ªî¡Áø‰ Fø‰ªî£L «òè£è ¬ñˆîF
Q¡øFõ¬ô «ð£‹ ªïPõN òP¾‹
ªê¡ø¶ ¹è½… ªêŒF¬ò »í«ó”.
The speciman is kept open in a glass bowl being exposed well in sunlight. Not
distrubed by wind then add one drop of gingelly oil by a glass rod observe about the
spreading of the oil drop on the surface.
vatham -Üóªõùc‡ì¶
pitham -ÝN«ð£™ðóMò¶
kapham  & ºˆªî£ˆ¶ G¡ø¶
In vatha pandu noi snake like spreading was observed.
Beside enn vagai thervugal disease can also be diagnosed by other methods
namely thinaigal, paruvakalangal,uyir thathukal,udal thathukal. Hence a through
knowledge about the disease can be attained systematically and properly in siddha
system of medicine. A combination of all these diagnostic creteria is very helpful to
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attain a proper diagnosis with a full  complete entity based on basic principles of
siddha science.
Thinaigal:
Thinai (or) Nilam is classified into five types depending on the surrounding,
vegetation,landscape and ecological state . Study of thinai is very much necessary.
Kurinji(Mountain and its surrounding):
“°P…C õ¼ GôˆFŸ ªè£Ÿø º‡® óˆî‹
àP…C õ¼²óº º‡ì£‹ & ÜPë¼¬ó‚
¬èò«ñ îƒ° îóˆ î£¬ñõ™¬ô »ƒèF‚°‹
äò«ñ îƒ° ñP”.
Liver disease, Fluorosis ,Haematological disorder are common in this land.
Mullai(Forest and its surrounding):
“º™¬ô Gôˆîò¬ñ ºKG¬ó «ñMÂñš
ªõ™¬ô G¬ôˆî Hˆî ªñƒ°Áƒè£¡ & Ü™ôªòQ™
õ£îªñ£N ò£îîµ‡ ñ¡Âñ¬õ õN«ï£ŒŠ
«ðîªñ£N ò£î¬øòŠ H¡¹”.
Vatha and pitha disease are common in this land.
Marutham(Field and its surrounding):
“ñ¼îGô ï¡m˜ õ÷ªñ£¡¬ø‚ ªè£‡«ì
ªð£¼î Gô ñ£Fò «ï£Œ «ð£‚°ƒ & è¼îGôˆ
î£Póî… Åö õ¼ˆ¶õ ªó¡ø£Ÿ HEªò™
ãPóî… Å›M‚° I™.”
30
It is a suitable land for the mankind for healthy living.
Neithal(Sea, seashore and its surrounding):
“ªïŒîQô «ñ½õ˜Š¬ð cƒè£ ¶PÂñ¶
ªõŒîQô «ñîƒ°iì£°‹ & ªï£Œb¡
ñ¼ƒ°ì¬ô º‚è£‚A õ™½ÁŠ¬ð i‚°ƒ
è¼ƒ°ì¬ô‚ WNøƒ°ƒ è£‡.”
-& ðî£˜ˆî °í C‰î£ñE.
Increased kapham causes oedema, elephantiasis, liver disease are common.
Palai(Dessert and its surrounding):
“ð£¬ô Gô‹ «ð£Ÿ ðì¬óŠ HøŠH‚è
«ñ¬ô Gô eò£¶ MKˆîŸ° & «õ¬ôGô
ºŠHE‚° I™ô£‹ º¬ø«òòõŸø£ô£‹
âŠHE‚° I™ô£ ñçªî¡.”
& ðî£˜ˆî °íC‰î£ñE.
Vatha, pitha, kapham and its related  disease’s are common in this land.
In all five thinai vatha pitham is probable of occurance.
Paruvakalangal(seasonal variation):
Earth take 12 month’s to rotate sun according to this year is divided into six
season they are
Kalam Tamil months English months
Kaarkalam Avani,Purattasi Monsoon
Koothir kalam Ipasi, karthigai Autumn
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Munpani kalam Margazhi, thai Winter
Pinpani kalam Maasi, panguni Prevernal
Ilavenil kalam Chithirai, vaigasi Spring
Muthuvenil kalam Aani, aadi Summer
Each season consists of 2 months each.
In all six seasons vatha pandu probaly occurs.
Udal vanmai(Immunity):
Udal vanmai is classified into three types they are
- Iyarkai vanmai
- Seyarkai vanmai
- kaala vanmai
Iyarkai vanmai:
Natural immunity of the body caused by mukkutram right from birth onwards.
Seyarkai vanmai:
Improving the health by intake of nutritious food, physical activites and by
medicine (or) Immunization.
Kaala vanmai:
Development of immunity according to age and environment.The alteration in
udal vanmai creates more possibilities to vatha pandu noi.
Uyir thathukal (mukkutram):
Uyir thathukal are
- vatham
- pitham
- kapham
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Which acts as an vital elements and it is the functional units of the body.
Vatham:
This is a kinetic energy,which enfluence all motions. It is located in abanan,
edakalai,motion,spermatic cord,pelvic bone,nerves, joints and muscles.Vatham
represents vayu,mind,dryness, pain, flatulence,sensitiveness,lightness and air.
They are classified into ten types,they are
1.Piranan(uyirkaal)
This is called as heart center. Piranan means the  forward or primary air
forces it controls breathing knowledge,mind and five sensory organs.
2. Abanan(Keelnokunkaal)
This corresponds to the pelvic plexus and is the seat of kundalini or material
energy situated in the naval region and expels faecal matter,urine , menstrual
flow,sperm and ovum constricts and spincter carries ingested food extracts to  the
respective places.
3. Viyanan(paravukaal)
This corresponds to the nasociliary plexus viyanan means the diffusive air  it
is responsible for the nutrition and movement of all movable and immovable parts
of the body causes the feeling of sensation.
4. Uthanan(mel noku kaal)
Corresponds to pharyngeal plexus present in throat region and controls
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breathings and speech uthanan means moves upward air force. It is responsible for
nausea vomiting and erucation.
5. Samanan (nadukaal):
Corresponds to solar plexus. Samanan means equalizing air it regulates all
other four main vital air forces and it aids proper digestion.
6. Naagan :
Responsible for higher intellectual function, causes opening and closing of
eye lids.
7. Koorman:
Responsible for vision and yawning.
8. Kirukaran:
Lies in the tongue, salivary and nasalsecretion causes hunger, concentration
of the mind on the particular thing  sneezing and responsible for taste sensation.
9. Devathathan:
Responsible for lazziness,sleeping and anger.
10.Dhananjayan:
Produce bloating of the body and escape on  third day after death. In case of
vatha pandu
S.No Names Features
1. Abanan Expells stools
2. Viyanan It carries nutrients all over the body
3. Udhanan Vomiting
4. Samanan Due to other  vayus are affected
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5. Kiruharan Appetite affected
6. Thevathathan Tiredness and sleep is affected
These vayus are affected in vatha pandu.
Pitham:
Pitham represents gastic juice,bile,energy, heat, anger and irritation. Located in
urinary bladder,heart,head, pingalai umbilicus, abdomen,piranan ,blood,sweat,skin and
eyes.
They are classified into five types
Name Features
Anal pitham (Gastric juice) Give  appetite and helps in digestion.
Pirasagam(Bile) Gives complexion to the skin
Ranjaga Pitham(Haemoglobin) Which colours the blood
Aalosagam(Aqueous humour) Brightens eyes and helps in vision
Saathaga pitham (Life energy ) Controls whole body
In case of vatha pandu noi
Anal pitham,Ranjagam, pirasagam and sathaga pitham is affected.
Kapham:
Kapham represents feeling of cold, heaviness, running nose, passing of
muscoid  discharge and also saliva.
Located in samanan, seminal fluid ,head,tongue,fat, bone marrow, blood,
nose, chest, nerves, bones, large intestine, stomach and pancreas.
classified into 5 types they are
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Name Features
Avalambagam In helps the heart in pumping and controls
other four kapham.
Kilethagam (saliva) Present in mucus secretion of mouth and
in mouth, makes food wet and helps in
mastication.
Pothagam(Lymph) Located in tongue and saliva and gives taste
sensation.
Tharpagam This is located in head controls
(cerebrospinal fluid) cerebrospinal fluid keeps head and eyes
cool.
Santhigam(synovial fluid) Located in joints which lubricates and aid
free movements of the joints.
In vatha pandu noi
Kilethagam, pothagam, Avalabagam are commonly affected.
UDAL THATHUKAL:
Udal thathukal are seven in number which constitutes the entire body.
1. Saaram: Contains nutrients from digested food and nourishes all tissue,
organs and system.
2. Senneer: Oxygenates all tissues and vital organs and maintains life.
3. Oon: Gives structure and shape to the body responsible for the
movements of the body.
4. Kozhuppu: Lubricates the joints and facilitates their functions.
5. Enbu: Protects all the internal organs and gives structure to the body.
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6. Moolai: Located in between the core of the bones and gives strength to
bones.
7. Sukkilam / Suronitham: Meant for reproduction incase of vatha pandu  Saaram,
senneer, oon,kozhuppu are affected mainly.
Noi nithanam:
Progosis:
According to yugimuni in yugi vaithia chinthamani vatha pandu noi is curable.
“î£ù£ù Hó«ñè‹ õ£î Å¬ô
ê£˜õ£ù cKN¾ °¡ñ «ó£è‹
ñ£ù£ù êò«ó£è… ê¡Q «î£ì‹
Ü´ˆîMìƒ è£ñ£¬ô ð£‡´ «ê£¬è
ñ£«ù «èœ èð«ó£è ñ‰Fó Mò£F
ñ…êœ«ï£Œ °¬ô«ï£¾ ðJˆFò «ó£è‹
áù£°‹ õ¼IìˆF™ ÜFê£óƒèœ
à‡ì£A™ Üê£ˆFò ñ£ ºÁFî£«ù.”
& êîè ï£®
In piramegam, vathasoolai, neerizhivu ,gunmam, shayam, sanni, kamalai, pandu,sobai,
kapha rogangal,manjal noi,paithiya rogam if diarrhoea occurs it  becomes worsen.
“ªî£°ˆF†ì cKN¾ «ñèÅ¬ô
²ói‚è… ê‰GõL «î£ì ñ£‰î‹
I°ˆF†ì Aó£EòF ê£ó‹ õ£î‹
Mì ð£è‰ Fóœ ð£‡´ «ê£¬è è£ñ£¬ô
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õ°ˆF†ì ªð¼‹ð£´ ñ…êœ «ï£¾
õ£Œ¾ óˆî Hˆîºì¡ ðô«ï£¾‚°
ð°ˆF†ì Þ¬÷Š¹ì«ù ²õ£ê‹ M‚è™
ðŸPù£™ ñóíªñ¡Á ð°ˆ¶„ ªê£™«ô.”
The above verse was quoted in sathaga naadi this denotes in paandu noi and in
other certain diseases if the combination of emaciation,dyspnoea and hiccough occurs
it causes poor progonosis of the disease.
“ªõŠ¹ HEòîQ™ ªõ‹«ñèˆî£™ õ¼‰F¡
îŠ¹I¬è c«óî£QøƒA¡ & ªêŠ¹‹
Aó£EJŸ ð£‡®™ A÷˜ c˜ ²¼ƒAŸ
Hó£í¡ HK»ªñùŠ «ð².”
(è‡µê£Iò‹)
The above quote denotes that scanty micturation in pandu noi causes death
of the patient.
In the above condition the prognosis of vatha pandu noi may be poor and it
becomes  incurable causes death.
Maruthuvam:
Our siddha treatment is not only for complete healing but also for the
prevention and rejuvenation. This is said as
Kappu( Prevention )
Neekam(Treatment)
Niraivu(Restoration)
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Siddha system has uneqivocally stated that even during the time of conception, some
defects creep into the fertilised embryo. The defects from the basis for the
manifestation of certain constitutional disease later on during the existence of  the
individual.
Diseases are produced  by the unequilibrium of three thathus which may be
due to various causes like diet, lifestyle, mental and physical activities .It is essential
to know the cause for the disease the nature of the patient and the severity of illness
and the seasons and the time of the occurance of the disease.
Line of treatment
The aim is to normalise the vitiated thathus and affected raktha thathu.
Effective medicinal preparations have to be administered in the beginning itself to
raise the raktha thathu to attain its normal functions.
Diet
Siddha system lays a great importance on the observation of rules regarding
diet in everyday life because the siddha system has rightly realised that the basic
factor of the body is food, that is Annamaya kosam is the first among the five
kosams constituting our physical and mental existence to prevent the occurrence of
the disease. elaborate inference regarding food item is our daily diet is given in the
text book of siddha.
Thirumoolar says
ñ¼‰«î àí¾ àí«õ ñ¼‰¶
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ñ£Áð£®™ô£î à‡® ñÁˆ¶‡E¡
áÁð£ ®™¬ôß» J˜‚°
& F¼õœÀõ˜
Herbs, Metals and Minerals commonly used for pandu noi
ªêŠ¹A«ø¡ ð£‡´ è£ñ£¬ô «ê£¬è
b˜‚A¡ø êó‚° õ£ŒM÷ƒ è‰î£‹
åŠH™ô£‚ ÃM¬÷ «õ˜ ïˆ¬î„ ÅK
áCñ™L ñ¼†Aöƒ° ï™ô«õ¬÷
åŠH™ô£ñ™ ÍLèKŠð£¡ êÍô‹
à¼‚° ñ‡º«ó ñò‹ è¬ó‚ ªè£¿‰¶
ªêŠð£‹Hˆ î¬÷ŠðŸð‹ ¹Oò‹ ð†¬ì
CÁ d¬÷ î£Œ‚ ªè£†ì£¡ CÁW¬ó«õ˜
«õ«ó£´ ªõ‡è£ó‹ Ì¬ùè‚ è£Q
Mˆ¶ Þ÷c˜ ºˆ¶ W›‚è£Œ ªï™L
«õ«ó£´ ÌI ê˜‚è¬ó‚ Aöƒ°
ªõœ÷£†®¡ c˜ð£™ ê£ó¬í «õ˜èœO
«õ«ó£´ üô ñ…êK„ ªê‰Éó‹
I÷° î‚è£OJ¬ô ªï™LJ¡ «õ˜
ªï™L «õ˜ F¬ù‚ è…C ºèñ™L
c˜ºœO êÍô‹ Ìõóê‹ ð†¬ì
ªè£™ô¡ «è£¬õ »¬ìò êÍô‹ õ†ì‚
40
A½A½Š¬ð õ£¬öc˜ õ£¬ö»†®
M™õ Þ¬ô ð£FK«õ˜ °÷ˆ¶Š ð£¬ô
«õ«ó£´ «è£Iòº‹ Üvõè‰F
è™ò£í èóŠð£¡ î‚«è£ô¼‹ Hó‹I
è£ó£¡FK è´° ð£¬ô °P…ê£
°P…ê£ ï£èí‹ ¹OJ¬ôJ «ù£´
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Diet Regimen for pandu noi
Consuming unbalance and incompatible diet is considered to be the prime
causative factor for upsetting the threedosha balance leading to manifestations of
various ailments regarding diet regimen in vatha pandu the following food items
are recommended.
Keerai vagaikal (greens)
Greens like Karisalai, Ponnanganni, Arukkeerai, Sirukeerai, Murungai Keerai
and manithakkali keerai having haematinic property may be given daily.
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Kaikarikal (vegetables)
Kathiri pinju, Avarai pinju, Murungai pinju, Vazhai kachal may be given along
with other food stuffs.
Pazhavakaigal (fruits)
Pereechai, Orange, Kodimunthiri, Naral, Apple, Atthi are also rich sources for
iron.
Easily digestable foods like kanji, Mutton soups, bone soups must be given in
acute stages of vatha pandu noi. The goat liver soup is given with orange (or) apple (or)
grape juice to these patients.
After the normal appetile is restored properly prepared flesh of kadai, kowthari,
and udumbu can also be given. They tone up the body in the debilitaling condition and
improve “Raktham” formation.
If oedema is present barley Kanjee prepared with vellarivithu. Poosani vithu can
be given. This will act as diuretic and reduce oedema.
When the symptoms were improved the patients were advised to practice Yoga
and pranayama according to their physical and mental conditions.
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MODERN ASPECT
INTRODUCTION
             Nutritional anemia is a global problem of immense public health significance,
affecting persons of all ages and economic group, it is more common among
preschool children’s, who are taking poor diet and pregnant women’s. It is ranked
as the commonest chronic woe of mankind. Around 30% of the total world population
is anaemic and half of these, some 600 million people have iron deficiency the
highest prevalence is in pre school children’s 47.4% and the lowest prevalence is in
men 12.7% about 55% of pregnant women’s are affected by this. Even affluent
section suffers from anemia due to ignorance of food. Actually anemia is the condition
in which the haemoglobin level in the blood is below the normal range and this is
discussed in various views.
The Blood and its components
                 Blood is the connective tissue in the fluid form, it is considered as the
fluid of life because it carries oxygen from lungs to all parts of the body and carbon
dioxide from all parts to the lungs. The blood is the red fluid of alkaline reaction
and is salty in taste. The whole blood volume of infants has been reported as
90ml/kg.
              Blood consists of blood cells which are called as formed elements and the
liquid portion known as plasma. The cell make up 40-45% of the total amount of
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the blood and plasma makes about 55-60% the cells consists of 90% of haemoglobin
and 10% of stroma.
Blood cells:
Three types of cells are present in blood they are
1. Red blood cells or erythrocytes
2. White blood cells or leucocytes
3. Platelets or thrombocytes
Erythocytes  or  Red Blood Cells:
Red blood cells are the non-nucleated formed elements in the blood. The
red colour of these cells is due to the presence of the colouring matter haemoglobin
in these cells.
The red blood cell count ranges between 4 to 5.5millions/cu mm of   blood.
In adult males it is 5 millions/cu mm of blood.
In adult females it is 4.5 millions/cu mm of blood.
Shape and Size of Red Blood Cells:
Normal red blood cells, are biconcave  discs  having  a   mean  diameter of
about 7.8micrometer and a thickness  at the thickest  point  of  2.5 micrometer and
44
in the center of 1micrometer  or less. The average volume of the red blood cell is   90
to 95 cubic micrometers.
              The  shapes  of  red blood cells  can  change  remarkably as  the  cells  pass
through  capillaries. Actually, the red blood cell is a “bag” that can be deformed into
almost any shape. The normal cell has a great excess of cell  membrane for quantity
of material inside, deformation does not stretch the membrane greatly and
consequently, does  not  rupture  the  cells, as  would  be  the  case  with  many  other
cells.
Functions of the blood:
* Transport of oxygen from lungs to the tissues to utilize metabolic process
* Carry CO2  from tissues to lungs
* Transports nutrients, other metabolites, hormones from the source to the site
of usage, action or exertion.
* Responsible for maintain the thermoregulatory mechanism in the body
* Carries materials that clot blood preventing its loss from a ruptured blood
vessel
* Blood communicates between the cells of different parts of the body
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Erythropoiesis:
   Is the process which involves the origin, development and maturation of erythrocytes.
Site of Erythropoiesis:
Areas of the body that produce red blood cells
* In the early few weeks of embryonic life – yolk sac
* During the middle trimester of gestation – liver, spleen and lymph nodes
* Later part of gestation and after birth – red bone marrow
* Up to the age of five – red bone marrow of all bones
* From the age of six to twenty – red bone marrow of proximal end of long bones
and all the membranous (flat) bones.
* After the age of twenty – from membranous bones like vertebra, sternum, ribs,
scapula, iliac bones and skull bones and from the end of long bones.
* During bone disorders the RBC are produced in spleen
Genesis of Red Blood Corpuscles:
       In the bone marrow there are cells called pleuripotent hemopoietic stem cells
(PHSC) from which all the cells in the circulating blood are derived. The larger of
reproduced stem cells differentiate to form the other cells, even though they have
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already become committed to a particular line of cells and are called committed stem
cells.
      The different committed stem cells will produce colonies of specific type of blood
cells. Therefore committed stem cells that produces colony forming unit blast (CFU
– B) and then erythrocytes are produced from this are called colony – forming unit –
erythrocytes (CFU – E).
         Growth and reproduction of the different stem cells are controlled by multiple
proteins called growth inducers the another set of proteins are called differentiation
inducers whose function is differentiation of the cells.
Stages of Erythropoiesis:
Pluripotent  hemopoietic stem cells

Colony forming blastocytes

Colony forming unit erythrocytes (CFU-E)

Proerythrocyte
(first cell that belonging the RBC series unipotential)

Early normoblast or basophil erythroblast
(begins synthesis of heamoglobin)

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Intermediate normoblast

Late normoblast
(with small nucleus and more haemoylobin orthochromic erythroblast)

Reticulocyte
(small amount of basophilic reticulum is present)

Erythrocytes
(matured red blood corpuscles)
Regulation of Erythropoiesis:
        Tissue oxygenation is the basic regulator of red blood cells production. Any
condition that causes the quantity of oxygen transported to the tissues to decrease
(hypoxia) ordinarily increases the rate of red blood cells production. Main conditions
being very high altitudes, anemia, prolonged cardiac failure and lung diseases.
        Erythropoietin is the circulating hormone which is the principle factor that
stimulates red blood cells production. It is a glycoprotein with a molecular weight
of about 34,000. Hypoxia causes marked increase in erythropoietic production.
         Kidney produce about 90% of all erythropoietin in a normal person, the
remaining is formed from the liver. Epinephrine, norepinephrine and several of the
prostaglandins stimulates erythropoietic production.
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Substances Necessary for the Formation of Red Blood Cells
1. Protein
Hemoglobin synthesis depends on adequate supply of the proper amino acids
for the synthesis of globin and clinical, experimental evidence show that anemia
can be caused are aggregated by protein deficiency.
2. Iron
About 15mg of iron is needed daily for growing children and women. This is
essential for the proper hemoglobination of red blood cells in their later stages of
maturation i.e. red corpuscles. A deficiency of iron causes hypochromic microcytic
anemia.
3. Copper
Traces of copper are essential for the utilization of iron in the synthesis of
hemoglobin.
4. Manganese
          Probably act as a catalyst.
5. Vitamins
           Vitamin B12 and folic acid are the bone marrow stimulants. Vitamin B12 along
with the intrinsic factor present in the stomach act as proerythroblastic stage. So
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that if it is absent the maturation is defected to the megalocytic series of cell instead
of forming normoblast.
          Vitamin A. vitamin C is also a bone marrow stimulant acting at any particular
stage of maturation. Its deficiency causes normocytic type of anemia.
6. Internal secretions
           Thyroxine is a general metabolic stimulant which increases the tissues activity
and oxygen demand, to this demand the bone marrow response adenocorticotrophic
hormone and cortisones appear to have some relationship with the red cell formation.
7. Bile
          Bile appears to help the absorption of iron and utilization of iron by the tissues.
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                                              HEMOGLOBIN
Hemoglobin is the colouring matter of RBC. It is a chromoprotein forming
95% of dry weight of RBC and 30 to 34% of wet weight. The function of hemoglobin
is to carry the respiratory gases. It also acts as a buffer.
Structure of Hemoglobin:
Hemoglobin is a conjugated protein. It consists of a protein combined with an
iron containing pigment. The protein part is globin and iron containing pigment is
heme. Heme also forms a part of structures of myoglobin (oxygen binding pigment in
muscles) and neuroglobin (oxygen binding pigments in brain). Iron is normally present
in ferrous form. The pigment part is called porphyrin. It is formed by four pyrole
rings. The rings are attached to one another by methane bridges. Globin consists of
four polypeptide chains. Two are alpha and two are beta. The molecular weight of
hemoglobin is 68,000.
Synthesis of Hemoglobin:
              Synthesis of hemoglobin actually starts in proerythroblastic stage. However
hemoglobin appears in the intermediate normoblastic stage only. The production of
the hemoglobin is continued until the stage of reticulocyte. The Heme portion of
hemoglobin is synthesized in mitochondria from acetic acid and the glycine.
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The sequence of events in synthesis of hemoglobin:
* During Krebs cycle, the acetic acid is converted into succinyl CoA.
* Two molecules of succinyl CoA combine with two molecules of glycine to form
pyrole compound.
* Four pyrole compounds combine to form protoporohyrin
* Protoporphyrin is of many types. Only protophyrin IX is involved in the
formation of heme molecule by combining with iron.
* Each heme molecule combines with one globin molecule to form hemoglobin.
Combination of Hemoglobin with Oxygen:
The primary function of hemoglobin is to combine with oxygen in the lungs
and then to release this oxygen readily in the tissue capillaries where the gaseous
tension of oxygen is much lower than in lungs. One gram of hemoglobin combines
with about 1.39 ml of oxygen.
Destruction of Hemoglobin:
After the lifespan of 120 days, the RBC is destroyed in the reticuloendothelial
system particularly in spleen and the hemoglobin is released into plasma. Soon, the
hemoglobin is degraded in the reticuloendothelial cells and split into globin, iron
and porphyrin.
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Globin is utilized for the resynthesis of hemoglobin. Iron is stored in the body
as ferrritin and hemosiderin, which are reutilize for systhesis of new hemoglobin.
Porphyrin is convered into a green pigment called biliverdin.in human being, most of
the biliverdin is converted into a yellow pigment called birirubin. Bilirubin and
biliverdin are together called the bile pigment.
Normal Values:
 Average hemoglobin content in blood is 14 to 16 gms%. However the value
varies depending upon the age and sex of the individual.
Age
At birth – 25 gms%
After third month – 20 gms%
After one year – 17 gms%
From puberty onwards – 14 to 16 gms%
Sex
Adult males – 15 gms%
Adult females – 14.5 gms%
Packed cell volume ( haematocrit value )
Men – 40 to 50 %
Women – 35 to 47 %
Infants – 44 to 62 %
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Children (one year) – 36 to 49 %
Children (10 to 12 year) – 37 to 44 %
Mean Corpuscular Volume (MCV)
Adult – 76 to 96 Cubic microns
Infants (3 month) – 83 to 110 Cubic microns
Children (1 year) – 77 to 101 Cubic microns
Children (10 to 12 years) – 77 to 95 Cubic microns
Mean corpuscular diameter
Adult -6.6 to 7.7 microns
 Mean Corpuscular Hemoglobin (MCH)
( 100 )
( )
Hb Concentration grams per mlMCH
RBC Count Million per ml

Adults – 27 to 32 pico grams
Mean Corpuscular Hemoglobin Concentration (MCHC)
         
100
100
Hb in grams per mlMCHC
Volume of Packed Cell per ml

         The average value is 35 ± 3 percent.
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                                                  IRON METABOLISM
Iron is important for the formation of hemoglobin, myoglobin and other
substance like cytochrome ,cytochrome oxidase, peroxidase and catalase.
Normal Value and Distribution of Iron in the Body:
   The total quantity of iron in the body is about 4 grams. The approximate distribution
of iron in the body is as follows:
        In the hemoglobin                                       : 65 to 68 %
        In the muscle as myoglobin                         : 4 %
        As intracellular oxidative heme compound : 1%
        In the plasma as transferring                       : 0.1%
        Stored in the reticuloendothelial system      : 25 to 30 %
Dietary Iron:
    Dietary iron is available in two forms called heme and nonheme. Heme iron is
present in fish, meat and chicken. Non heme iron is available in vegetables, grains,
and cereals.
Rich : Liver, egg yolk, oyster, dry beans, dry fruits, yeast.
Medium : Meat, chicken, fish, spinach, banana, apple,
Poor : Milk and its products, root vegetables.
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Daily Requirement of Iron:
Adult male : 0.5-1mg
Adult female : 1-2mg
Infants : 60µg/kg
Children : 25µg/kg
Pregnancy women : 3 – 5mg
Iron requirement (mg) = 4.4× body weight× Hb deficit
Absorption of Iron:
Iron is mainly absorbed from the small intestine. It is absorbed through cells
by pinocytosis and transports into the plasma. Bile is essential for the absorption of
iron.
Transport and Storage of Iron:
Immediately, after absorption into the blood, iron combines with a â globin
called apotransferrin to form transferrin and is transported in this form in the plasma.
Iron combines loosely with the globin and can be released easily at any region of
the body.
Iron is stored in large quantities in the reticuloendothelial cells and liver
hepatocytes. In other cells also, it is stored in small quantities. In the cytoplasm of
the cell, iron is stored as ferritin in the large amount. Small quantity of iron is also
stored as hemosiderin.
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Daily Loss of Iron:
In males, about 1 mg of iron is excreted every day through feces. In females,
the amount of iron loss is very much high. This is because of the menstruation.
One gm of hemoglobin contains 3.34 mg of iron. Normally, 100 ml of blood
contains 15 gm of hemoglobin and about 50 mg of iron (3.34 × 15). So, if 100 ml of
blood is lost from the body, there is loss of about 50 mg of iron. In females, during
every menstrual cycle, about 50 ml of blood is lost by which 25 mg of iron is lost.
That is why the iron content is always less in females than in males.
Iron is lost during hemorrhage and blood donation also. If 450 ml of blood is
donated, about 225 mg of iron is lost.
Regulation of Total Blood Iron:
Absorption and excretion of iron are maintained almost equally under normal
physiological condition. When the iron storage is saturated in the body, it
automatically reduced the further absorption of iron from the gastrointestinal tract
by feedback mechanism.
The factors which reduce the absorption of iron are:
1. Stoppage of apotransferrin formation in the liver, so that, the iron could not
be absorbed from the intestine.
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2. Reduction in the release of iron from the transferring so that, transferring is
completely saturated with iron and further absorption is prevented.
ANEMIA
                Anemia refers to a state in which the level of haemoglobin in the blood is
below the reference range appropriate for age and sex. It is one of the common
blood disorders it is refers to reduction in Red blood cell count, Hemoglobin content,
packed cell volume.
Generally anemia occurs because of:
1. Decreased production of RBC
2. Increased destruction of RBC
3. Excess loss of blood from the body
All these incidents are caused either by inherited disorders or environmental
influences such as nutritional problem, infection and exposure to drugs or toxins. In
these conditions, the change is noticed not only in hemoglobin content but also in
the morphologic features of the RBC.
Aetiology:
1. Blood loss
2. Impaired red cell production
3. Inadequate supply of nutrients essential for erythropoiesis such as,
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a. Iron deficiency
b. Vitamin B12 deficiency
c .Folic acid deficiency
d. Protein-caloric malnutrition
e. Other less common deficiency
4. Depression of erythropoietic activity
5. Anemia associated with chronic disorders such as
a. Infection
b. Connective tissue disorder
c . Inflammatory disorders
d. Disseminated malignancy
6. Anemia associated with renal failure
7. Anemia due to replacement of normal bone marrow by
a. Leukemia
b. Lymphoma
c . Myeloproliferative disorders
d. Myeloma
Classification of Anemia
Anemia is classified by two methods
A. Morphological classification
B. Etiological classification
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Morphological Classification:
Morphological classification depends upon the size and colour of RBC. Colour
is determined by quantity of hemoglobin, according to this anemia is classified into
four types.
1. Normocytic Normochromic Anemia
The size and heamoglobin content of RBC are normal but the number of RBC
is less.
2. Macrocytic Normochromic Anemia
The RBC is larger in size with normal hemoglobin content, the RBC count
decreases.
3. Macrocytic Hypochromic Anemia
The RBCs are larger in size. The hemoglobin content in the cell (MCH) is
less so the cells are pale in colour.
4. Microcytic Hypochromic Anemia
The RBCs are smaller in size and the hemoglobin content (MCH) is less.
Etiological Classification
On the basis of etiology anemia is classified into five types:
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1. Hemorrhagic anemia.
2. Hemolytic anemia.
3. Nutritional deficiency anemia.
4. Aplastic anemia.
5. Anemia of chronic disease.
1. Hemorrhagic anemia:
Anemia due to hemorrhage is known as hemorrhagic anemia. It occurs both
in acute and chronic hemorrhagic condition. Hemorrhage occurs in conditions like
accident, ulcer, excessive uterine bleeding, purpura and hemophilia.
Acute Hemorrhage – it refers to sudden loss of large quantity of blood as in
the case of accident. Within about 24 hours of hemorrhage, the plasma portion of
blood is replaced. However the replacement of RBC does not occur quickly and it
takes at least 4-6 weeks. So with less number of RBCs hemodilution occurs. However
morphologically the RBCs are normocytic normochromic. Decreased RBC count
causes hypoxia which stimulats the bone marrow to produce more number of RBC.
So, this condition is corrected within 4 to 6 weeks.
Chronic Hemorrhage – It refers to loos of blood by internal or external
bleeding over a long period of time. It occurs in conditions like peptic ulcer, purpura,
hemophilia and Menorrhagia.
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 Due to continuous loss of blood, lot of iron is lost from the body causing iron
deficiency. This affects the synthesis of hemoglobin resulting in less hemoglobin
content in the cell. The cell also becomes small. Hence the RBCs are microcytic
and hypochomic.
2. Hemolytic Anemia
 Hemolysis means destruction of RBCs. Hemolytic anemia occurs because of
excess destruction of RBCs.
Causes of excess hemolysis are:
1. Liver failure
2. Renal disorder
3. Hyperspleenism
4. Burns
5. Infection like malaria and septicemia
6. Poisoning chemical substances like lead, coal and tar
7. Presence of isoagglutinins like anti Rh
8. Congenital or acquired default in the shape of RBCs.
When the shape is abnormal, RBCs become more fragile and hemolysis occur
easily. It occurs in two inherited conditions called sickle cell anemia and thalassemia.
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Sickle cell anemia
It is a congenital anomaly and found mostly in blacks. It is due to the abnormal
hemoglobin called hemoglobin S (normal adult hemoglobin is hemoglobin A). In this,
alfa chains are normal and beta chains are abnormal. The molecules of hemoglobin S
polymerize into long chains and precipitate inside the cell. Because of this, RBCs
attain sickle (crescent) shape and become more fragile leading to hemolysis.
In children, hemolyzed sickle cells aggregate and block the blood vessels leading
to infraction (stoppage of blood supply). The infraction is common in small bones.
The infracted small bones in hand and feet results in varying length in the digits. This
condition is known as hand and feet syndrome. Jaundice also occurs in these children.
Thalassemia
It is also known as Cooley’s anemia or Mediterranean anemia. It is more common
in Thailand and to some extent in Mediterranean countries. This type of anemia is due
to the inherited anomalies of hemoglobin.
Thalasemia is of two types:
1.   thalassemia
2.   thalassemia
The   thalassemia is very common among these two:
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In normal hemoglobin, the number of   and   poly peptide chains is equal. In
thalassemia the production of these chains become imbalanced because of defective
synthesis of globin genes. This causes the precipitation of in poly peptide chains in
the immature RBCs leading to distributions in process of erythropoiesis. The
precipitation also occurs in mature red cells resulting in hemolysis.
The   thalassemia occurs in fetal life or infancy in this   chains are less, absent
or abnormal with excess of   chains. This leads to defective erythropoiesis and
hemolysis. The infants may be stillborn or may die immediately after birth.
In â thalassemia â chain are less in number, absent or abnormal and there is on
excess of á chains. á chains precipitate causing defective erythropoiesis and hemolysis.
3. Nutrition Deficiency Anemia
Nutritive substances such as iron, proteins and vitamins like C,B12 and folic acid
are necessary for erythropoiesis. The deficiency of these substances leads to nutrition
(nutritional) deficiency anemia.
Iron Deficiency Anemia:
Iron deficiency anemia is most common type of anemia. It develops due to
inadequate availability of iron for hemoglobin synthesis. The RBCs are microcytic
and hypochromic.
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Causes of Iron Deficiency Anemia are
1. Loss of blood
2. Decreased intake of iron
3. Poor absorption of iron from intestine
4. Increased demand for iron in condition like growth and pregnancy
The feature of iron deficiency anemia are brittle nails, spoon shaped nails
(koilonychias), brittle hair, atrophy of papilla in tongue and dysphagia.
 Protein Deficiency Anemia:
Due to deficiency of protein the synthesis of hemoglobin is reduced. The
RBCs are macrocytic and hypochromic.
Pernicious Anemia or Addisons Anemia:
It is due to atrophy of the gastric mucosa because of autoimmune destruction
of parietal cells, the gastric atrophy results in decreased production of intrinsic factor
and poor absorption vitamin B12  which is the maturation factor of RBC. The RBCs
are larger and immature with almost normal hemoglobin content. So, cells are
macrocytic and normochromic.
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Before knowing the cause of this anemia, it was very difficult to treat the
patients and the disease was considered to be fatal. So, it was called pernicious anemia.
The synthesis of hemoglobin is almost normal in this type of anemia.
Pernicious anemia is common in old age and it is more common in females
than in males. It is associated with other autoimmune diseases like disorders of thyroid
gland, Addison’s diseases, etc. The characteristic feature if this type of anemia are
lemon yellow colour of skin (due to anemic paleness and mild jaundice) and red sore
tongue. Neurologically disorders such as paresthesia (abnormal sensations like
numbness, tingling, burning etc) progressive weakness and ataxia (muscular
incoordination) are also observed in extreme conditions.
Megaloblastic anemia
Megaloblastic anemia is due to the deficiency of another maturation factor
called folic acid. Here the RBCs are not matured. The DNA synthesis is also defective
so the nucleus remain immature. The RBCs are megaloblastic and hypochromic.
The feature of pernicious anemia appear in megaloblastic anemia also.
However,neurologically discords may not develop.
4. Aplastic Anemia
Aplastic Anemia is due to the disorder of red bone marrow. The red bone marrow
is reduced and replaced by fatty tissues. It occurs in conditions like repeated exposure
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to X-ray or gamma ray radiation and by the presence of bacterial toxins, quinine, gold
salt, benzene, radium etc., it is common in tuberculosis and viral infections like hepatitis
and HIV infection. The cells are normocytic and normochromic.
5. Anemia of Chronic Diseases
Anemic of chronic diseases is the second common type of anemia (next to iron
deficiency anemia). It is characterized by short life span of red cell caused by
disturbance in iron metabolism or resistance to erythropoietin action. Anemia
develops after few months of sustained diseases.
Common cause of this type of anemia is:
i. Non-infectious inflammatory diseases such as rheumatoid arthritis (chronic
inflammatory auto immune disorder affecting joints)
ii. Chronic infection like tuberculosis (infection caused by mycobacterium
tuberculosis) and abscess ( collection of pus in the infected tissue in lungs)
iii. Neoplastic disorders (abnormal and disorganized growth in tissue or organ) such
as Hodgkin’s diseases (type of malignancy involving lymphocytes) and cancer of lung
and breast.
The red cells are generally normocytic and normochromic in this type of anemia.
However, in progressive disease associated with iron deficiency the cell become
microcytic and hypochromic.
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Types of anemia Causes Morphology of RBC
Hemorrhagic anemia Acute loss of blood Normocytic, Normochromic
Chronic loss of blood Michrocytic, Hypochromic
Hemolytic anemia 1.Liver failure Normocytic, Normochromic
2. Renal disorder
3. Hypersplenism
4. Burns
5. Infections- malaria
and septicemia
6. Poisoning by chemicals
like lead, coal and tar
7. Isoagglutinins- anti Rh
8. Congenital or acquired Sickle cell anemia-sickle
default in the shape of shape
RBCs
Thalassemia: small and
irregular
Nutritional deficiency Iron deficiency Microcytic Hypochromic
anemia
Protein deficiency Macrocytic, Hypochromic
Vitamin B12 deficiency Macrocytic, Hypochromic/
Normochromic
Folic acid deficiency Megaloblastic,
Hypochromic
Aplastic anemia Bone marrow disorders Normocytic, Normochromic
Anemia of chronic 1.Non-infectious Normocytic, Normochromic
diseases inflammatory diseases
2. Chronic infection
3. Neoplastic disorder
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Iron Deficiency Anemia
Iron deficiency is the most common nutritional deficiency in the world and
the most common cause for anemia world wide the factors which influence the
prevalence of anemia include socio-economic status, dietary patterns, the degree of
urbanization, educational background and accessibility to health care facilities
prophylaxis programmes and the prevalence of worm infestations in the population.
Etiology:
The etiology varies with the age, sex and country of residence of the patient
I. Increased Blood Loss:
1. Uterine
Eg: a) Excessive menstruation in reproductive years
b) Repeated miscarriages
c) At onset of menarche
d) Post menopausal uterine bleeding
e) Uterine cancer
2. Gastrointestinal
a) pepticulcer
b) Hemorrhagic gastritis
69
c) Gastric carcinoma
d) Colonic carcinoma, Haemorrhoids
e) Hook worm or pin worm diseases
f) Oesophagal varices
g) Hiatus hernia
h) Chronic aspirin ingestion
i) Ulcerative colitis and crohn diseases
ii) Diverticulosas
3. Nose
Recurrent epistaxis
4. Renal tract
a) Haemoturia
b) Hemoglobinuria
5. Lungs
a) Haemoptysis
II. Increased Requirements
Growing infants, children, Adolescents
Pre menopausal women
Menstruation
Pregnancy and lactation
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III. Inadequate Dietary Intake
Poor economic status
Anorexia in pregnancy
Elderly individuals due to poor dentition, apathy and financial constraints
IV. Decreased Absorption
Partial or total gastrectomy
Achlorhydria
Intestinal malabsorption such as coelic disease pica
Females in reproductive period
The highest incidence of IDA is in women during their reproductive period
it may be from the following causes
1.Blood loss:
Persistant and heavy menstrual blood has due to insertion of IUCD’s may
due to repeated miscarriage
2. Inadequate intake
3. Increased Requirements – during parturition and lactation.
Post menopausal females
Due to carcinoma of the uterus, bleeding from alimentary tract such as
carcinoma of stomach etc,.
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Adult males – very rare
Infants and children’s -IDA is fairly common during 1-2 years of age
Hook Worm Infestation (Ankylostomiasis):
It is the important cause of intestinal blood loss. Parasite ancylostoma
duodenale and nector americanus attaches to the proximal portion of the small intestine
and suck blood from sub mucosal vessels. The amount of blood lost is a function of
hookworm load,which turns in proportional to the number of ova in the stool each
worm which has been in the intestine for months or years draws 0.2-0.5 ml of blood/
day. It has been estimated that the loss of hemoglobin for every twelve worms may be
one percent feacal ova counts in excess of 500 g are associated with iron losses of
more than 3 to 4 mg/day and a high incidence of IDA.
Regulation of iron in the body
When the body has become saturated with iron the rate of absorption of iron
from intestinal tract becomes greatly decreased whereas if the iron stores is depleted
of iron the rate of absorption is accelerated to 5 or more times than the normal rate
of absorption.
Clinical features
* General
Weakness, fatigue, lassitude, swelling of the body and oedema, pallor, dry skin,
lusterless hair, white sclera, spoon shaped deformity of nails(koilonychias)
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* Cardiovascular System
Palpitation, breathlessness, angina pain, sinus tachycardia, collapsing pulse,
dancing carotids, full neck veins, dilated heart with slightly shifted apex, functional
systolic murmur over pulmonary and mitral area (haemic murmur), venous hum,
congestive cardiac failure.
* GI tract
Anorexia, acidity, heartburn, palpable spleen and liver, clay,  ice cube or
starch pica.
* Neurological
Dizziness, giddiness, tingling, numbness, insomnia, dimness of vision,
forgetfulness, lack of concentration , loss of memory.
* Reproductive system
Amenorrhoea, Menorrhagia, abortion, infertility.
* Renal system
Slight proteinuria may be present in severe anemia.
* Pyrexia –mild pyrexia may occur with severe anemia but marked fever is due to
either the causative disorder or to some complicating factor.
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Clinical features due to epithelial tissue changes
This is seen in few individuals having long standing iron deficiency anemia
particularly in middle-aged women.
* Tongue
Atrophic glossitis resulting in bald tongue with soreness sometimes
leukoplakia.
* Mouth – angular stomatitis with glossitis.
* Oesophagus
Obstruction of the oesophagus from spasm or rarely by a band or web
consisting of denuded, aggregated epithelial cells may be seen in X-ray as “post
cricoids web”
* Nail - Brittle, thinned out, flattened and sometimes spoon shaped nail.
* Hair - Thin and lustreles.
The association of chronic iron deficiency anemia with koilonchyia, glossitis,
dysphagis and splenomegaly is called Plummer-Vinson syndrome or Paterson-kelley
syndrome.
Complication of IDA
* IDA may be the present finding in gastrointestinal carcinoma
* In patients with heart disease, severe anemia may precipitate angina pectoris or
congestive heart failure.
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* Infections are more common in IDA especially those of the respiratory,
gastrointestinal and urinary tracts.
* Chronic IDA reduces the efficacy in work and study.
Differential Diagnosis
In a patient with hypochromic microcytic anemia the major diagnostic
possibilities are
i) Iron deficiency
ii) Thalassemia
iii) Anemia of chronic infection
iv) Sideroblastic anemia
Several laboratoty test are useful in the different at diagnosis.
i) Thalassemia
It mild forms of thalassemia microcytosis is much more marked than
hypochromic accordingly the MCHC is usually normal the red cell distribution is
more uniform than that in iron deficiency. Target cella and basophilic stippling are
usually more prominent in thalassemia than iron deficiency, the serum iron is normal
or elevated.
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ii) Anemia of chronic infection
The serum iron is decreased the transferring level is also decreased the
laboratory tests are not very helpful in determining whether a patient with chronic
inflammatory disease such as rheumatoid arthiritis has become iron deficiency.
iii) Sideroblastic anemia
The diagnosis of sideroblastic anemia rests on the demonstration o ringed
sideroblasts in the marrow these patient often have a population of hypochromic
microcytic red cells eventhough red in cell indexes are usually normal.
Investigations:
I) Blood Investigation
1. Total red blood cell count
2. Differential count
3. Erythrocyte sedimentation rate
4. Mean corpuscular hemoglobin
5. Mean corpuscular volume
6. Mean corpuscular hemoglobin concentration
7. Packed cell volume
8. Red cell survival
9. Serum iron
76
10. Serum ferritin concentration
11. Serum protein
12. Serum creatinine
II) Urine investigation
1. Urine sugar
2. Urine albumin
3. Deposits
Red blood cells
Pus cells
III) Stools Investigation
1. Occult blood
2. Ova
3. Cyst
4. Red blood cells
5. Pus cells
From the above investigation the following are predominant in iron deficiency
anemia
* In IDA the hemoglobin may fall to as low as 3gm/100ml but the red cell count is
rarely below 2.5 million/cubic millimeter.
* The red cells are usually microcytic and hypochromic.
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* Reticulocyte and platlets are normal or increased.
*  The white cell count is normal serum iron is usually below 30 mug/100 ml
(normal is 90-150 mug/100 ml)
* Bone marrow hemosidering is absent
* The MCHC is below 27gm/dl.
Diagnostic Features of Iron Deficiency Anemia:
Following criteria are essential to diagnose iron deficiency anemia
* History of inadequate intake of dietary iron and blood loss if any
* Typical symptoms and signs like easy fatigubility, waxy pallor, pica,
koilonchyia, smooth tongue, dysphagia associated with general consideration
* Erythrocyte count may be normal or reduced less than 3 million/cumm
* Reduction in hemoglobin below 10 mg%
* Hypochromic and microcytic morphology of peripheral smear
* Low serum iron, increased total iron binding capacity
* Serum ferittin level is reduced
* Reduced mean cell volume
* Platlet count is either normal or raised
* Bone marrow haemociderin absent
* Occult blood present in stools
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Management
This can  be considered as follows
1. Correction of anemic state – overall correction of nutrition with articles rich in
iron is important, iron deficiency is corrected by intake of rich iron content diet
and administration of medicinal iron,
2. Replacement of iron stores
3. Elimination of the causes
DIET
Haem iron sources
Muscle meat
Organ meat (e.g.liver)
Fish and shell fish
Non Haem iron sources - Oatmeal, legume (peas, beans) dried nuts, whole meal,
green leafy vegetables, fortified iron salt, cereal foods, food rich in vitamin c in the
same meal enhances iron absorption.
Prophylaxis
There are three main principles in the prevention of nutritional iron deficiency
anemia.
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1. The regular consumption of a well balanced diet containing an adequate quantity
of iron.
2. The periodic administration of iron as drug during increased physiological
demands of women e.g. pregnancy, lactation and menstruation.
3. Maintenance of a normal hemoglobin level in the mother is desirable for the
prevention of iron deficiency anemia infants, premature and unduly small infants
should be given prophylactic iron as a routine therapy, iron rich sources should
be added in the infants diet from the third or fourth month and thereafter be
progressively increased. Following control of infection, iron should be given
to all infants and children’s if the hemoglobin level is reduced.
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MATERIALS AND METHODS 
 An open labelled randomised clinical trial on “Vatha Pandu” was 
conducted in Government Siddha Medical College and Hospital, 
Palayamkottai, Tirunelveli. Totally fourty cases were selected 20 patients 
treated as OP remaining 20 patients were treated as IP. The clinical signs and 
symptoms of “Vatha Pandu” of both sexes of different ages were selected and 
studied under the guidance of the professor, reader and lecturer of P.G. Pothu 
Maruthuvam Department. 
Preparation of Trial Medicine 
 The trial medicine ‘Karisalankanni chooranam’ is selected based on 
their medicinal values in treating ‘Vatha Pandu’ as mentioned in the siddha 
literature Sigitcharathnadeepam – part II (page no.162). The ingredients are 
collected and purified and the medicine were prepared, stored and dispensed in 
pockets containing 2gms each to the patients based on the reference cited 
above. 
Parameters for case selection 
 Cases were selected from outpatient and inpatient department.  
Inclusion criteria  
The parameters for the selection were insidious  
Onset of easy fatigubility 
Weakness 
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Headache 
Bodyache 
Inability to concentrate 
Giddiness 
Pallor of skin 
Conjunctiva 
Mucous membrane of lips and pale tongue 
Koilonychia 
Hb level between 7.1-10 gm% 
Worm infestations. 
Exclusion criteria 
 Patients are excluded in the following conditions  
Hb less than 7 
Congenital heart disease 
 Chronic renal diseases 
History of liver diseases 
Inherited defects 
Haemorrahgic disorders 
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Thalassemia 
Ischemic heart disease 
Thyroid disorder 
Diabetes mellitus. 
Withdrawal criteria 
 Patient are advised to withdraw in following conditions Intolerance to 
the drug and development of any serious adverse effects during the trial, 
Patients turned unwilling to continue in the course of clinical trial, Poor 
compliance, Any other acute illness which need rescue medication and to 
follow regular diet schedule. 
Clinical examination 
 Patients were subjected to physical examination on siddha methodology 
“Piniyari Muraimai”. It has three main principles which are Poriyal Arithal, 
Pulanal Arithal and Vinathal and effected through ‘Envagai Thervugal’. 
Coming to the modern methodology detailed clinical history was recorded. All 
the patients are subjected to the following investigations 
Siddha Assesment 
 Neerkuri – Physical Urine examination. 
 Neikuri – Oil examination 
 Naadi paritchai(including Envagaithervugal) – Pulse examination 
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Investigations 
 Blood - Complete blood analysis TC, DC, Hb, TRBC, ESR, PCV. 
MCV, MCH, MCHC, Peripheral blood smear were carried out. 
 Routine Urine Analysis- Albumin, Sugar, Deposits, Bile salts, Bile 
pigment are noted. 
 Stools- for Ova, Cyst and Occult blood were also done. 
 Biochemical Analysis- Serum Cholesterol, Serum Protein, Serum 
Bilirubin, Serum Ferritin, TIBC, Blood Sugar, Blood urea are carried out 
before the treatment and at the time of discharge. 
Methods of Treatment 
 Siddha system of medicine is based on mukkutra theory and hence the 
treatment is mainly aimed to bring down the three dhoshas to its equilibrium 
state and thereby restoring the physiological condition of three dhoshas. 
 The clinical improvement was followed and it was recorded in the case 
sheet. 
 Bio-chemical and Pharmacological studies of the drug were done to 
make out the active principles and action of the trial medicine. 
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OBSERVATION AND RESULTS 
               The results were observed on the basis of the following criteria by 
conducting clinical study on 20 inpatients and 20 outpatients totally 40 patients. 
 Sex  Distribution 
 Age Distribution 
 Kaalam 
 Paruvakaalam 
 Thinai 
 Occupational status 
 Socio economic status  
 Food habits 
 Personal habits 
 Aetiological  factors 
 Mukkutram- Vatham, Pitham, Kabam 
 Ezhu Udal Thathukkal 
 Enn vagai Thervugal 
 Neerkuri , Neikuri 
 Clinical Features and prognosis 
 Haemoglobin  level 
 Assessment  of  results  by  Laboratory investigation. 
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1.SEX  DISTRIBUTION 
Sl.No Sex 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. Male 5 6 25 30 
2. Female 15 14 75 70 
 
 
 
Inference : 
  Among 40 cases, 29 Patients were females  and  11 Patients were  males. 
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2.AGE  DISTRIBUTION 
Sl.No Age in Years 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. 12-20 (Years) 1 - 5 - 
2. 21-30 (Years) 2 1 10 5 
3. 31-40 (Years) 2 1 10 5 
4. 41-50 (Years) 9 3 45 15 
5. 51-60 (Years) 6 15        30 75 
 
 
Inference: 
  Out of 40 patients, 21 Patients were in the age group of 51-60,  12 Patients 
were in the age group of  41-50,  3 Patients were in the age group of 31- 40, 3 Patients 
were in the age group of 21-30, 1 Patient were   in the age group of  12-20. 
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3. DISTRIBUTION  OF  KAALAM 
Sl.No Kalam 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. VathaKaalam 
 0- 33 years  
4 1 20 5 
2. 
 
PithaKaalam 
34-66 years  
 
16 19 80 95 
3. 
KabhaKaalam 
67-100 years 
 
- - - - 
 
 
Inference: 
  Out of 40 patients, 5 Patients comes under VathaKaalam and 35 Patients  
comes under  PithaKaalam. 
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4.PARUVAKAALAM  DISTRIBUTION: 
Sl.No 
Paruva 
Kaalam Months 
No. of 
Cases 
Percentage  
(%) 
OP IP OP IP 
1. Kaarkaalam Avani, Puratasi, Mid Aug-Mid Oct 
0 0 0 0 
2. Koothirkaalam Iyppasi, Kaarthigai Mid Oct-Mid Dec 
0 0 0 0 
3. Munpani Margazhi, Thai Mid Dec-Mid Feb 
7 0 35 0 
4. 
Pinpani Maasi, Panguni Mid Feb-Mid April 
13 9 65 45 
5. 
Elavenil 
Chithirai, vaigasi 
Mid April- Mid 
June 
0 11 0 55 
6. 
Mudhuvenil Aani, Aadi Mid June-Mid Aug 
0 0 0 0 
 
 
Inference: 
Out of 40 patients, 22 Patients comes under Pinpani , 11 patients comes under 
Elavenil, 7 Patients comes under Munpani kaalam. 
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5.DISTRIBUTION OF THINAI 
Sl.No Distribution 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. 
Kurinji 
0 0 0 0 
2. 
Mullai 
1 1 5 5 
3. 
Marutham 
18 17 90 85 
4. 
Neithal 
1 2 5 10 
5. 
Paalai 
0 0 0 0 
 
 
Inference: 
Out of 40 patients, 35 Patients comes under Neithal  and  5  patients  comes 
underMarutham. 
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6. OCCUPATIONAL  STATUS 
Sl.No 
Occupational 
Status 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. Students 2 1 10 5 
2. Labours 5 7 25 35 
3. House  wife 9 12 45 60 
4. Office   going 4 0 20 0 
 
 
Inference: 
Out of 40 patients, 21 Patients were House wife, 12 Patients were Labours, 4 were 
office going and remaining 3 Patients are students. 
 
 
 
10
5
25
35
45
60
20
0
0
10
20
30
40
50
60
70
OP IP
Pe
rc
en
ta
ge
 (%
)
Cases
Students Labours House  wife Office   going
 
 
92 
7. SOCIO-ECONOMIC STATUS  
Sl.No Income / Month 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. Low income group 
(Below 20,000) 
16 17 80 85 
2. 
Middleincome         
group (20,000-
50,000) 
4 3 20 15 
3. High income group  
(Above 50,000) 
0 0 0 0 
 
 
Inference: 
  Out of 40 patients, 33 Patients belongs  to low income group , 7 Patients   
belongs  to  middle income  group. 
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8.DIETARY HABITS  
Sl.No Dietary Habits 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. Vegeterian 5 4 25 20 
2. Mixed 15 16 75 80 
 
 
 
Inference: 
  Out of 40 patients, 31 Patients were mixed diet and 9 Patients were vegetarian. 
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9. AETIOLOGICAL  FACTORS 
Sl.No Aetiology 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. Nutritional 
Deficiency 
18 19 90 95 
2. Blood Loss 
Menorrhagia 
2 1 10 5 
3. Piles 0 0 0 0 
 
 
Inference: 
Out of 40 patients, 37 patients were  due to  nutritional  deficiency. 
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10.DISTRIBUTION OF  VATHAM 
Sl.No Vatham No. of Cases Percentage  (%) OP IP OP IP 
1. Pranan 20 20 100 100 
2. Abanan 6 5 30 25 
3. Viyanan 20 15 100 75 
4. Samanan 20 20 100 100 
5. Uthanan 0 0 0 0 
6. Nagan 0 0 0 0 
7. Koorman 0 0 0 0 
8. Kirugaran 0 0 0 0 
9. Devathatthan 20 20 100 100 
10. Thananjeyan 0 0 0 0 
 
 
Inference: 
  Pranan, samanan, devathathan were affected in all patients, Abanan affected in 
11 patients, Vyanan  affected  in 35 patients. 
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11.DISTRIBUTION OF  PITHAM 
Sl.No Pitham 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. Analagam 20 20 100 100 
2. Ranjagam 20 20 100 100 
3. Saathagam 20 20 100 100 
4. Pirasagam 8 10 40 50 
5. Alosagagam 0 0 0 0 
 
 
Inference: 
Out of 40 patients, Analagam, Ranjagam, Sathagam were affected  in all  patients, 
Pirasagam  were affected  in 18 patients. 
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12.DISTRIBUTION OF  KABAM 
Sl.No Kabam 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. Avalambagam 20 20 100 100 
2. Kilethagam 20 20 100 100 
3. Pothagam 0 0 0 0 
4. Tharpagam 0 0 0 0 
5. Santhigam 5 9 25 45 
 
 
Inference: 
Out of 40 patients, Avalambagam  and  Kilethagam affected in  all patients, 
Santhigam affected in 14 patients. 
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13.EZHU UDAL THATHUKKAL 
Sl.No Ezhu Udal Thathukkal 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. Saram 20 20 100 100 
2. Seneer 20 20 100 100 
3. Oon 0 0 0 0 
4. Kozhuppu 0 0 0 0 
5. Enbu 3 2 15 10 
6. Moolai 0 0 0 0 
7. Suronitham 0 0 0 0 
 
 
Inference: 
Out of 40 patients, Saaram and  senneer  affected  in  all patients. 
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14.ENN VAGAI THERVUGAL  
Sl.No Envagai Thervugal 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. Naadi 20 20 100 100 
2. Sparism 0 0 0 0 
3. Naa 20 20 100 100 
4. Niram 20 20 100 100 
5. Mozhi 6 10 15 25 
6. Vizhi 20 20 100 100 
7. Malam 6 5 30 25 
8. Moothiram 0 0 0 0 
 
 
Inference: 
  Naa, Niram ,Vizhi and Naadi were affected all patients,  Malam affected in 11 
patients. 
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15.NAADI 
Sl.No Naadi 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. Vathakabam 14 16 70 80 
2. KabhaPitham 6 4 30 20 
 
 
 
Inference: 
  30 patients had Vathakaba Naadi,  and 10 patients had Kabhapitha Naadi . 
 
 
 
 
70
80
30
20
0
10
20
30
40
50
60
70
80
90
OP IP
Pe
rc
en
ta
ge
 (%
)
Cases
Vatha kapham KabaPitham
 
 
101
16. NEIKURI 
Sl.No Neikuri 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. Vatham(Snake like) 10 12 50 60 
2. Pitham (Ring like) 2 4 10 20 
3. Kabham(Pearl  Like) 8 4 40 20 
 
 
Inference: 
  Out of 40 patients, 22 patients had Vatha Neer, 12 patients had Kabha Neer  
and 6 patients had  Pitha Neer Neikuri. 
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17. CLINICAL FEATURES 
Sl.No Clincal Features No. of Cases Percentage  (%) 
OP IP OP IP 
1. Pallor  of  conjunctiva  and  nail bed 20 20 100 100 
2. Fatigue 20 20 100 100 
3. Loss  of  appetite 20 20 100 100 
4. Dyspnoea  on  exertion 20 20 100 100 
5. Head ache 15 14 75 70 
6. Glossitis 3 3 15 15 
7. Constipation 6 5 30 25 
8. Giddiness 10 8 50 40 
9. Tachycardia 2 3 10 15 
10. Dimnished of  vision 0 0 0 0 
 
 
Inference:      
  Out of 40 patients, 40 patients had  Pallor  of  conjunctiva  and  nail bed,  
Fatigue, Loss of  appetite, Dyspnoea on exertion, 29 Patients had  Headache, 6 
patients had  Glossitis, 11 patients had  Constipation, 18 patients had Giddiness  and 
Tachycardia. 
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18. CLINICAL PROGNOSIS 
Sl.No 
Signs & 
Symptoms 
Before Treatment After Treatment 
No. of 
Cases 
Percentage 
(%) 
No. of 
Cases 
Percentage 
(%) 
OP IP OP IP OP IP OP IP 
1. 
Pallor of  
conjunctiva  and 
nail  bed 
20 20 100 100 
1 1 5 5 
2. Fatigueness 20 20 100 100 1 1 5 5 
3. Loss  of  appetite 20 20 100 100 1 1 5 5 
4. 
Dyspnoea  on 
exertion 
20 20 100 100 
3 2 15 10 
5. Headache 15 14 75 70 1 3 5 15 
6. Glossitis 3 13 15 15 1 0 5 0 
7. Constipation 6 5 30 25 0 0 0 0 
8. Giddiness 10 8 50 40 0 0 0 0 
9. Tachycardia 4 4 20 20 0 0 0 0 
 
 
Inference:    
 After  treatment  Pallor of conjunctiva  and  nail bed , Loss  of appetite  and  
Fatigueness  present  in 2 patients, Dyspnoea on exertion present in 5 patients, 
Headache  present  in 4 patients, Glossitis  present  in 1 patient. 
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19.HAEMOGLOBIN  LEVEL OF OUT PATIENTS 
S. 
No 
O.P. 
No NAME 
BeforeTreatment 
(gms/dl) 
AfterTreatment 
(gms/dl) 
1. 12963 Kalaivani 9.4 12.4 
2. 12866 Janani 8.3 11.5 
3. 13206 Sivaranjani 9.6 12.6 
4. 13962 Shanthi 9.2 11.5 
5. 13963 Pappathi 9.1 12.5 
6. 14074 Kalyani 8.8 12 
7. 15376 Rajeshwari 7.8 11.6 
8. 15622 Maheswari 7.1 10.2 
9. 16301 Mary 7 10.5 
10. 17775 Geetha 7.7 10.4 
11. 18972 Murugan 9.4 12.7 
12. 19107 Anantham 9.8 11.8 
13. 19538 Chelladurachi 9.9 12.4 
14. 19597 Rekha 7 8.2 
15. 24459 Sundari 8.3 11.5 
16. 20311 Kowdhulalam 9.4 12.6 
17. 20371 Jesuraj 9.8 11.5 
18. 21436 Leela 9.5 12.5 
19. 21913 Ganesan 8.5 12 
20. 21914 Subramanium 8 11.6  
 
 
105
20. HAEMOGLOBIN  LEVEL OF IN PATIENTS 
S. 
No 
I.P. 
No NAME BeforeTreatment(gms/dl) AfterTreatment(gms/dl) 
21. 401 Pichammal 8 11.6 
22. 478 Pappa 9.6 12 
23. 571 Shanmugakani 9.2 12.2 
24. 406 Jothi 9 12.1 
25. 611 Selvabackiyam 9 12.5 
26. 667 Subbu 8.4 11.5 
27. 736 Thaiammal 8.6 11.6 
28. 544 Gomathi 8.8 11.8 
29. 954 Ponnukutti 8 10.2 
30. 962 Sendu 9.3 11.5 
31. 980 Pappa 8.5 11.1 
32. 983 Gurusamy 8.8 11.8 
33. 953 Muthu 9.8 12 
34. 1000 Rathinammal 9.2 10.5 
35. 1025 Varatharajan 7.6 8.7 
36. 1070 Murugan 8.5 11.5 
37. 1105 Mohammed 8.4 10.5 
38. 1121 Subammal 7.2 10.5 
39. 1148 Perumal 9.1 12.5 
40. 964 Mookkammal 8.4 11.5 
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21. GRADING OF RESULTS 
Sl.No Grading of results 
No. of Cases Percentage  (%) 
OP IP OP IP 
1. Good Response 16 15 80 75 
2. Moderate Response 3 3 15 15 
3. Poor Response 1 2 5 10 
 
 
 
 
Good Response : Increase in Hb 3gm%and above after treatment 
Moderate Response : Increase in Hb 2gm%after treatment 
Poor Response:  Increase in Hb 1gm% after treatment 
Inference:       
Out of 40 patients, 31 cases showed good result, 6 cases showed moderate result,               
3 cases showed poor result. 
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ANNUXURE I
TRIAL DRUG
PREPARATION AND PROPERTIES OF TRIAL MEDICINE
KARISALANKANNI CHOORANAM
INGREDIENTS:
S.N Name Botanical Name Parts used Quantity
1. Karisalankanni Eclipta prostrata Dried Leaves 4 parts
2. Mookiratai Boerhaevia diffusa Dried Whole plant 1 part
3. Chukku Zingiber officinale Dried Rhizome 1 part
4. Milagu Piper nigrum Dried Seed 1 part
5. Thippili Piper longum Dried Fruit 1 part
6. Kadukkai Terminalia chebula Dried Thol 1 part
7. Nellikkai Phyllanthus emblica Dried Fruit 1 part
8. Thandrikai Terminalia bellerica Dried Fruit 1 part
9. Maramanjal Coscinium fenestratum Dried Wood 1 part
10. Thaniya Coriandrum sativum Dried Fruit 1 part
11. Athimathuram Glycyrrhiza glabra Dried Root 1 part
12. Karunseeragam Nigella sativa Dried Seed 1 part
13. Thalisapathiri Abies spectabilis Dried Leaves 1 part
14. Elam Elettaria cardamomum Dried Seed 1 part
15. Seeragam Cuminum cyminum Dried Seed 1 part
METHOD OF PREPARATION:
The purified drugs are powdered separately and sieved in pure white cloth, then the
powder of all the drugs are mixed and taken as a compound preparation.
DRUG DOSAGE: 2 gm , twice a day after food. With sugar.
INDICATION OF TRIAL MEDICINES: Vatha Paandu (Anaemia)
REFERENCE:  Sigitcharathnadeepam Part II,Page no 162.
2.MOOKIRATAI
Common name Í‚Aó†¬ì
Botanical name Boerhaavia diffusa
Family Nyctaginaceae
Synonyms ¹†ðè‹, Í‚°ø†¬ì, Þóˆî¹†Hè£
Part used whole plant
Chemical constituents Punaravine,sitosterol, aminoacid, fatty acids
Characters:
Suvai - kaippu
Thanmai - veppam
pirivu - karppu
°í‹
Yî ñèŸÁ‰ Fùõì‚°ƒ è£‰F î¼‹
õ£î M¬ù¬ò ñ®‚°ƒè£‡ & «ðF
ªè£´‚° ñ¬î à‡ì£‚è£Ÿ «è£ñ÷«ñ Hˆî‹
Ü´‚°«ñ Í‚°ó†¬ì ò£Œ.
(ÜèˆFò˜ °íõ£èì‹)
Action:
Expectorant, Diuretic, laxative, refrigerant, anthelmintic, emetic.
4.MILAGU
Common name I÷°
Botanical name Piper nigrum
Family Piperaceae
Synonyms èL¬ù, èP, «è£÷è‹, ñ£ê‹, ê¼ñð‰î‹,
ñ¬ôò£O Fóƒè™.
Part used seed
Chemical constrituents Chavicine , piperine , piperidine, pipertine, oleoresin.
Characters:
Suvai - kaippu, karppu
Thanmai - veppam
 pirivu - karppu
°í‹
“Yî²ó‹ ð£‡´ C«ôˆñƒ Aó£E °¡ñ‹
õ£î‹ Ü¼CHˆî‹ ñ£Íô‹ & æ¶ê¡Q
ò£êñðv ñ£ó‹ Üì¡ «ñè‹ è£êI¬õ
ï£êƒ èP I÷Aù£™” - &ÜèˆFò˜ °íõ£èì‹
Action:
Carminative, Antiperiodic, Rubefacient, stimulant,Antivatha , Antidote.
6. KADUKKAI
Common name è´‚è£Œ
Botanical name Terminalia chebula
Family combretaceae
Synonyms Ü‚«è£ì‹, Üƒèí‹, Üðóí‹, Ü¬ðò¡,
Ü‹¼î£, ÜKîA, «êîA, Müò«õî¡, õù¶˜‚A
Part name Thol
Chemical constituents Tannin, gallicacid, chebulin, chebulinic acid.
Characters
Suvai - Thuvarppu
Thanmai - Veppam
Piravi - Inipu
°í‹
“î£¬ì è¿ˆî‚A î£½ °PJMìŠ
d¬ì CLðîºŸ «ðFºì‹ & Ý¬ìªò†ì£ˆ
ÉôI® ¹‡õ£î «ê£Eè£ ñ£¬ôJó‡
ì£ôI® «ð£‹ õK‚è£ ò£™.” & ÜèˆFò˜ °íõ£èì‹
8 .THANDRIKAI
Common name î£¡P‚è£Œ
Botanical name Terminalia bellerica
Family Combretaceae
Synonyms Üºî‹, è‰îè†ðô‹, õ£‰Fò‹, Ìîõ£êè‹,
î£E‚è£Œ
Part used fruit
Chemical constituents Tannic acid
Characters:
Suvai - Thuvarppu
Thanmai - veppam
Pirivu - Inippu
Action:
Astringent,expectorant, laxative, tonic
10. THANIYA
Common name îQò£, ªè£ˆ¶ñ™L
Botanical name Coriandrum sativum
Family Apiaceae
Synonyms à¼œ ÜKC
part used Dried fruit
Chemical constituents Fattyacid, volatile oil, flavanoides
Characters:
Suvai - karppu
Thanmai - seetha veppam
Pirivu - karppu
°í‹:
“ªè£ˆ¶ñ™L ªõŠð‹ °O˜è£Œ„ê™ Hˆîñ‰î…
ê˜ˆFM‚è™ î£èªñ£´ î£¶ ï†ì‹ & èˆFªò¿‹
õ£î Mè£˜ñì˜ õ¡è˜ˆî HMóí‹
ÌîôˆF™ õ£îèŸÁ‹ «ð£ŸÁ”.
&ÜèˆFò˜ °íõ£èì‹
Action:
Stomachic, carminative, stimulant,Diuretic
12. THALISAPATHRI
Common name î£OêðˆFK
Botanical name Abies spectabilis
Family Taxaceae
Synonyms î£Oêðˆð‹
Part used Leaves
Chemical constituents Taxol, Taxine ,Tannin,Ephedrine
Characters:
Suvai - karppu
Thanmai - veppam
Pirivu - karppu
°í‹
“ï£C è÷ŠHEèœ ï£†ð†ì & è£ê…²
õ£ê‹ Ü¼C õ¬ñƒè£™  & iCõ¼
«ñè ñ‰î‹ ÜˆF²ó‹ M†«ì°ˆ î£Oˆî£™
Ý°… ²èHóêõ‹”.
Action:
Stomachic, Carminative,Expectorant, Tonic.
14. SEERAGAM
Common name Yóè‹
Botanical name Cuminum cyminum
Family Apiaceae
Synonyms Ü¬ê, YK, àð°‹ðdê‹, «ð£êù°«ì£K
Part used Seed
Chemical constituents Thymene,Cuminol,Cymene
Characters
Suvai - karppu
Thanmai - Thatpam
Pirivu - Inippu
°í‹
“HˆîªñÂ ñ‰FK¬òŠ H¡ùŠ ð´ˆFòõ¡
êˆ¶¼¬õ »‰¶ø‰¶ ê£Fˆ¶ & ñˆîªùÂ‹
ó£ê¬ù» eªõ¡Á ï‡¬ðŠ ðôð´ˆF
«ð£êù °ì£K ªê»‹ «ð£˜”. & «îó¡ ªõ‡ð£
Action:
Carminative, stimulant, stomachic, Astringent.
ANNEXURE – II 
BIO-CHEMICAL ANALYSIS OF KARISALANKANNI CHOORANAM 
Preparation of the extract:   
  5gms of the trial drug was weighed accurately and placed in a 250ml clean 
beaker. Then 50ml of distilled water was added and dissolved well. Then it is 
boiled well for about 10 minutes. It is cooled and filtered in a 100ml volumetric 
flask and then it is make up to 100ml with distilled water. This fluid was taken 
for analysis.    
QUALITATIVE ANALYSIS 
S.NO EXPERIMENT OBSERVATION INFERENCE 
1.  TEST FOR CALCIUM 
2ml of the above prepared extract is taken 
in a clean test tube. To this add 2ml of 4% 
Ammonium oxalate solution 
A white precipitate 
is formed 
Indicates the 
presence of 
calcium 
2. TEST FOR SULPHATE 
2ml of the extract is added to 5% Barium 
chloride solution. 
A white precipitate 
is formed 
Indicates the 
presence of 
sulphate 
3.  TEST FOR CHLORIDE   
The extract is treated with silver nitrate 
solution 
No  white 
precipitate is 
formed 
  Absence of 
chloride 
4. TEST FOR CARBONATE 
The substance is treated with concentrated 
Hcl.  
No Brisk 
effervessence is 
formed 
Absence of 
carbonate 
5. TEST FOR STARCH 
The extract is added with weak iodine 
solution 
No Blue colour is 
formed 
Absence of  
starch 
 6.  TEST FOR FERRIC IRON 
The extract is acidified with Glacial acetic 
acid and potassium ferro cyanide. 
No blue colour is 
formed 
Absence of 
Ferric iron 
7. TEST OF FERROUS IRON  
The extract is treated with concentrated 
Nitric acid and Ammonium thiocyanate 
solution 
Blood red colour is 
formed 
Indicates the 
Presence  of 
ferrous Iron. 
8.  TEST FOR PHOSPHATE 
The extract is treated with ammonium 
Molybdate and concentrated nitric acid 
No Yellow 
precipitate is 
formed 
Absence  of 
Phosphate 
9.  TEST FOR ALBUMIN 
The extract is treated with Esbach’s 
reagent 
No Yellow 
precipitate is 
formed 
Absence of 
Albumin 
10.  TEST FOR TANNIC ACID 
The extract is treated with ferric chloride. 
Blue black 
precipitate is 
formed 
Indicates the 
presence of 
Tannic acid 
11.  TEST FOR UNSATURATION 
Potassium permanganate solution is added 
to the extract 
It gets 
decolourised. 
 
Indicates the 
presence of   
unsaturated 
compound 
12.  TEST FOR THE REDUCING SUGAR 
5ml of Benedict’s qualitative solution is 
taken in a test tube and allowed to boil for 
2 minutes and add 8-10 drops of the 
extract and again boil it for 2 minutes. 
Colour develops 
Indicates the 
presence of 
Reducing 
sugar 
13.  TEST FOR AMINO ACID 
One or two drops of the extract is placed 
on a filter paper and dried well. After 
Violet colour is 
formed 
Indicates the 
presence of 
Amino acid 
drying, 1% Ninhydrin is sprayed over the 
same and dried well. 
14. TEST FOR ZINC 
The extract is treated with Potassium 
Ferrocyanide. 
No white 
precipitate is 
formed 
Absence of 
Zinc. 
 
Inference: 
  The extract prepared from the sample Karisalankanni chooranam 
contains calcium, sulphate, ferrous iron, tannic acid, reducing sugar and amino 
acid, unsaturated compound. 
  Biochemical Analysis report was given by Mrs. N.Nagaprema, M.Sc., 
H.O.D, Bio Chemistry Department, Government Siddha Medical College, 
Palayamkottai. 
 
ANNUXURE III
ACUTE TOXICITY STUDY
Acute oral toxicity refers to those adverse effects occurring following oral
administration of a single dose of a single dose of a substance or multiple doses given
within 24 hours. Acute toxic class method (OECD guidelines 423, (2000) was followed
to arrive at the maximum safety dose of the drug extracts. Three Wistar strain female
albino rats (8-12 weeks old, 180-200g body weight) were used in each group. Single
dose (2g/kg) of the Karisalankanni chooranam was orally administered to overnight
fasted (food but not water withheld) animas while control animals received the vehicle
(0.3%w/v CMC). Animals were observed individually after dosing at least once during
the first 4 hrs and daily thereafter, for a total of 14days. Body weights of the animals
were recorded. The other observations include changes for skin, fur, eyes and mucous
membranes, respiratory, circulatory and autonomic and central nervous system and
somatomotor activity and behavior pattern. At the end of 14 days, all animals were
subjected to gross necropsy.
Statistics
Data are expressed as mean ± SEM; data analysed by one way ANOVA
followed by Dunnet’s multiple range tests to determine the significance of the
difference between the control group and rats treated with test compounds.
* Values were considered significant at P < 0.5.
Results
Acute toxicity study
All of the rats fed with the food sample showed normal general behavior,
respiratory pattern, cardiovascular signs, motor activities, reflexes and normal change
in skin and fur.
S.No Parameter Control Sample 2g/kg
1 White blood cells (xlOVul) 9.36±0.54 8.53±0.19
2 Hemoglobin (g/dl) 11.50tb0.26 12.09±1.42
3 Mean corpuscular volume 60.45±2.3 58.16±3.5
4 Mean corpuscular hemoglobin
cone, (g/dl) 34.56±0.86 30.25±1.39
5 Platelet (xlO’/ul) 5.60±0.52 4.29±0.26
6 Red blood cell (xl06/ul) 3.87±0.24 1.29 ± 1.25
Hematological values of Karisalankanni chooranam in the acute toxicity study
Table - 2
S.No Parameter Control Sample 2g/kg
1 White blood cells (xlOVul) 9.36±0.54 8.53±0.19
2 Hemoglobin (g/dl) 11.50tb0.26 12.09±1.42
3 Mean corpuscular volume 60.45±2.3 58.16±3.5
4 Mean corpuscular hemoglobin
cone, (g/dl) 34.56±0.86 30.25±1.39
5 Platelet (xlO’/ul) 5.60±0.52 4.29±0.26
6 Red blood cell (xl06/ul) 3.87±0.24 1.29 ± 1.25
Values are expresses as Mean ± S.E.M.
All groups were treated with oral dose of 2g/kg body weight
No significant different from normal control
S. No Parameter Control Sample 2g/kg
1 Glucose (mg/dl) 148.75±3.96 151.03 ±0.31
2 BUN(mg/dl) 34.26±1.23 30.18± 1.29
3 Creatinine(mg/ dl) 0.46±0.06 0.40±0.01
4 Total protein (g/dl) 5.48±0.23 6.91±0.18
5 Albumin (g/dl) 3.49±0.62 2.45 ±0.13
6 Total bilirubin (mg/dl) 0.26±0.02 0.31 ±0.13
7 AST (u/1) 141.5±3.76 138.23 ± 1.82
8 ALT (u/1) 86.36±1.75 83.28 ±1.48
9 ALP (u/1) 75.57±2.16 75.02 ± 3.62
Table - 3
S. No Parameter Control Sample 2g/kg
1 Glucose (mg/dl) 148.75±3.96 151.03 ±0.31
2 BUN(mg/dl) 34.26±1.23 30.18± 1.29
3 Creatinine(mg/ dl) 0.46±0.06 0.40±0.01
4 Total protein (g/dl) 5.48±0.23 6.91±0.18
5 Albumin (g/dl) 3.49±0.62 2.45 ±0.13
6 Total bilirubin (mg/dl) 0.26±0.02 0.31 ±0.13
7 AST (u/1) 141.5±3.76 138.23 ± 1.82
8 ALT (u/1) 86.36±1.75 83.28 ±1.48
9 ALP (u/1) 75.57±2.16 75.02 ± 3.62
Blood chemical values of food sample in the acute toxicity study Values are
expresses as Mean ± S.E.M.
All groups were treated with oral dose of 2g/kg body weight No significant
different from normal control
Discussion and conclusion
In acute toxicity study for 14 days, at a dose of 2g/kg of Karisalankanni
chooranam sample were chosen for the experiment. In the aspect of general
behaviors, the rats treated with food sample at a single dose had no signs of behavior
changes and toxic signs. The treated groups revealed no significant differences in
body weight gain. The increase in body weight may have resulted from physiological
changes in rats such as metabolism, food and water intake.
HAEMATINIC ACTIVITY
“Evaluation of Haematinic Activity of the Karisalankanni chooranam
on Phenyl Hydrazine Induced Anaemic Rats”
MATERIALS AND METHODS
Phenyl hydrazine (PHZ) used for induction of Anaemia and the standard
drug Haematenic - Vit B12 syrup was purchased from authorized suppliers.
Experimental Animals The experiment was conducted in Wistar Albino
rats of either sex, weighed 150-200g from the animal house of Periyar college of
pharmaceutical sciences, tiruchirapalli. The animals were maintained under standard
laboratory condition with food and water ad libitum. The animals were allowed to
acclimatize for 2 weeks before being subjected to experimental protocol. The animals
were treated in line with the guide and care of laboratory animals as approved by the
Institutional Animal Ethical Committee.
PROCEDURE
Induction of Anaemia The aim of the study is to evaluate the efficacy of
Karisalankanni chooranam in iron deficiency anaemia. So anaemic wistar albino
rats are used for study. Phenyl hydrazine an haemotoxicity chemical is used to induce
anaemia in rats. Animals were divided into four groups containing six animals in
each.
However, the result from animal health monitoring in the entire period of 14days
showed no sign of morbidity and diseases.
The albino Wistar rats were healthy as shown by the normal appearance of
general behavior, respiratory pattern, cardiovascular signs, motor activities, reflexes
and normal change in skin fur.
With regards to hematological values, most of values in treated groups were
normal in comparison with the control group. Significantly, some values were
different from those of the control group such as RBC, MCV, MCHC, and platelet.
However, such values are within the normal ranges. These variations may have
resulted from variation among animal groups (Feldman et al., 2000) (Inala et al.,
2002). Therefore, these results suggest that the test drug did not cause hematological
or immunological defects in rats.
Furthermore, blood chemical examination was performed in order to evaluate
any toxic effects on liver. In this study, the levels of these blood chemical values
were minor changes and remained within the normal range (Casley and King, 1980)
(Levine, 1995) (Angkhasirisap et al., 2002).
In conclusion, Karisalankanni chooranam sample given orally to Wistar rats
did not produce toxicities.
Group I served as control and received regular rat food and drinking water
ad libitum.
Group II, III and IV rats received phenylhydrazine 10 mg/kg for 8 days orally
to induce anaemia in rats. Rats that developed anaemia with haemoglobin
concentration lower than 13 g/dl were recruited for the study.
Tween 20 a vehicle received by group II.
Group III received standard haematinic drug vit B12 (10 ml/kg).
Group IV received Karisalankanni chooranam (400 mg/kg) diluted in a
vehicle tween 20. Treatment of the Animals The rats were randomly divided into
four groups (6 rats per group) and treated daily for 4 weeks. Group 2, 3 and 4
animals are anaemic induced by phenylhydrazine. Group I (control) - received only
water and food. These animals are not induced by anaemia. Group II (negative
control) - received only vehicle Tween 20 (10 ml/kg) Group III (positive control) -
received only Vit B12 syrup (1 ml/rat) a standard drug. Group IV -received 400 mg/
kg of Karisalankanni chooranam respectively. All administrations were by oral
intubation. The absolute dose of test drug given to the rat was calculated by the
body surface area ratio between human intended dosages against rat. All the groups
were treated orally as single dose daily for three week.
Haematological Parameters Analysis
All the rats were fasted overnight and 0.5 ml of blood was collected on next
day by puncturing Retro orbital sinus using capillary tube. The blood was collected
after induction of anaemia with PHZ and during the end of first, second and third
weeks of treatments. The red blood cell count (RBC), haemoglobin concentration
(Hb), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH)
and Packed cell volume (PCV) were determined using Haematogical analyzer HA -
22.
Statistical Analysis All the results were expressed as mean ± SEM of six
animals. Analysis of variance was performed by ONE WAY ANOVA followed by
Dunnet’s test. Probability values less than 0.01 were considered as significant. Result
Oral administration of Phenylhydrazine for 8 days induced anaemia in rats.
Karisalankanni chooranam used in the management of anaemia. As a result there is
an increase in the haematological parameters within 3 weeks compared to other
group of rats.
Haematinic activity of Karisalankanni chooranam in Phenyl hydrazine
induced Anaemia in Rat Phenyl hydrazine caused significant decrease (P < 0.05) in
Hb concentration, RBC count and haematocrit value in all rats indicating Anaemia.
After the administration of test drug Karisalankanni chooranam , the hematological
parameters are significantly increased (P < 0.05). The PHZ - induced Anaemia was
significantly reversed within one week of treatment with the test drug, reaching
maximum by the third week. The effect of Haematinic syrup was comparable to the
test drug Karisalankanni chooranam .
DISCUSSION
Iron deficiency anaemia is a common disease affecting women especially in
reproductive age. It is characterised by microcystic hypochromic RBC, in which
MCV and MCH are reduced. It occurs due to defective haemoglobin synthesis. Iron
in the body is used primarily for the synthesis of haemoglobin and normal
erythropoiesis requires 20-25 mg of iron per day. Due to chronic blood loss, increased
iron requirement, malabsorption of iron leads to iron deficiency. So administration
of iron required to manage the disease without side effect. It can be prevented by
increased dietary intake of iron and vit C for absorption. Administration of
Phenylhydrazine a haemotoxicity chemical induce anaemia. Rats under the
haemoglobin level 13 mg/kg are recruited for the study. The haematological
parameters such as PCV, MCV, MCH and Hb are moniterd for three weeks. After
three weeks of treatment with Karisalankanni chooranam the haematological
parameters reach the normal levels.
Effect of phenylhydrazine (10 mg/kg, o.p daily for 8 days) on some
haematological parameters (T=0) (RBC, Hb, PCV, MCH and MCV)
Parameters Group I GroupII GroupIII GroupIV
(control) (anaemic) (Standard) (test drug)
Hb(g/dl) 19.4±1.22 15.2±1.04 18.2±0.56 17.5±0.22
Pcv(%) 59.45±1.10 50.12±2.10 60.22±1.16 55.48±0.96
RBC(xl06 7.24±0.89 5.84±0.23 6.02±0.24 6.76±0.26
MCV(fl) 76.88±0.12 99.48±0.46 93.72±0.48 79.18±0.36
MCH(pg) 24.24±0.18 20.24±4.12 29.27±0.88 25.34±0.22
Satistically significant p<0.05 (in comparison with negative control))
Haematological parameter of rat after one week treatment
Parameters Group I GroupII GroupIII GroupIV
(control) (anaemic) (Standard) (test drug)
Hb(g/dl) 19.4±1.22 15.2±1.04 18.2±0.56 17.5±0.22
Pcv(%) 59.45±1.10 50.12±2.10 60.22±1.16 55.48±0.96
RBC(xl06 7.24±0.89 5.84±0.23 6.02±0.24 6.76±0.26
MCV(fl) 76.88±0.12 99.48±0.46 93.72±0.48 79.18±0.36
MCH(pg) 24.24±0.18 20.24±4.12 29.27±0.88 25.34±0.22
Values are expressed in terms of mean ±SEM OF 6 rats(ANOVA)
**P<0.05 as compared with negative control ***P<0.01 as compared with negative
control
Values are expressed in terms of mean ±SEM OF 6 rats(ANOVA)
Haematological parameter of rats after two week treatment
Parameters Groupl Group II GroupIII GroupIV
Hb(g/dl) 19.6±0.12 16.4±1.23 19.2±1.45 19.4±0.36
PCV(%) 59.84±0.46 50.24±0.44 60.32±0.21 57.18±0.18
RBC(xl06/uI) 7.28±2.46 5.96±0.24 6.20±0.44 5.44±0.23
MCV(fl) 76.02±0.88 94.02±0.67 77.64±0.42 79.24±0.28
MCH(pg) 26.12±0.22 32.12±0.42 30.17±0.66 29.77±0.52
Values are expressed in terms of mean ±SEM OF 6 rats(ANOVA)
Statistically significant p<0.05 (in comparison with negative control)
Haematological parameter of rats after three week treatment
parameters Groupl GroupII GroupIII GroupIV
Hb(g/dl) 19.7±0.12 16.6±1.24 19.4±2.68 19.8±1.44
PCV(%) 60.02±0.12 50.64±1.65 60.40±0.22 59.26±1.36
RBC(xl06/ul) 7.32±0.22 6.02±1.64 7.02±0.21 7.16±1.86
MCV(fl) 77.24±1.22 80.01±0.16 76.62±0.89 75.78±2.67
MCH(pg) 25.01±0.11 25.12±2.16 27.24±0.24 24.86±2.26
**P<0.05 as compared with negative control ***P<0.01 as compared with negative
control
Satistically significant p<0.05 (in comparison with negative control))
**P<0.05 as compared with negative control ***P<0.01 as compared with negative
control
DISCUSSION
Iron deficiency anaemia is a common disease affecting women especially in
reproductive age. It is characterised by microcystic hypochromic RBC, in which
MCV and MCH are reduced. It occurs due to defective haemoglobin synthesis. Iron
in the body is used primarily for the synthesis of haemoglobin and normal
erythropoiesis requires 20-25 mg of iron per day. Due to chronic blood loss, increased
iron requirement, malabsorption of iron leads to iron deficiency. So administration
of iron required to manage the disease without side effect. It can be prevented by
increased dietary intake of iron and vit C for absorption. Administration of
Phenylhydrazine a haemotoxicity chemical induce anaemia. Rats under the
haemoglobin level 13 mg/kg are recruited for the study. The haematological
parameters such as PCV,MCV,MCH and Hb are moniterd for three weeks(15). After
three weeks of treatment with Pitha Paandu Maathirai(PPM)the haematological
parameters reach the normal levels.
CONCLUSION
In this study the oral administration of Karisalankanni chooranam
significantly increases the haematological parameters from first week of treatement.
This study concluded the haematinc activity of Karisalankanni chooranam was
more effective than the standard haematinic drug.
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I. CASE SUMMARY OF OUT-PATIENTS 
 
 
S.No. OP. No Name 
Age/ 
Sex Occupation 
Duration of the 
illness 
Starting of 
Treatment 
End of 
Treatment 
No. of days 
Treated Results 
1. 12963 Kalaivani 24/F Student 6 Months 08.02.2016 08.03.2016 30  Good 
2. 12866 Janani 29/F Computer 
operater 
3 Months 08.02.2016 08.03.2016 30 Good 
3. 13206 Sivaranjani 20/F Student 6 Months 09.02.2016 09.03.2016 30 Good 
4.  13962 Shanthi 46/F Housewife 6 Months 11.02.2016 11.03.2016 30 Moderate 
5. 13963 Pappathi 50/F Coolie 6 Months 11.02.2016 11.03.2016 30 Good 
6. 14074 Kalyani 57/F Housewife 1 Months 11.02.2016 11.03.2016 30 Good 
7. 15376 Rajeshwari 41/F Housewife 3 Months 15.02.2016 15.03.2016 30 Good 
8. 15622 Maheshwari 43/F Housewife 1 Year 16.02.2016 16.03.2016 30  Good 
9. 16301 Mary 52/F Coolie 6 Months 18.02.2016 18.03.2016 30 Good 
10. 17775 Geetha 40/F Housewife 3 Months 22.02.2016 22.03.2016 30 Good 
11. 18972 Murugan 42/M Tailor 3 Months 25.02.2016 25.03.2016 30 Good 
12. 19107 Anantham 60/F Housewife 2 Months 26.02.2016 26.03.2016 30 Moderate 
13. 19538 Chelladurachi 50/F Coolie 1 Year 27.02.2016 27.03.2016 30 Good 
14. 19597 Rekha 43/F Computer 
Operator 
1 Year 27.02.2016 27.03.2016 30 Fair 
15. 20311 Gowdulaalam 60/M Retired Teacher 6 Months 01.03.2016 30.03.2016 30  Good 
16. 20371 Jesuraj 54/M Loadman 6 Months 01.03.2016 30.03.2016 30 Moderate 
17. 21436 Leela 57/F Housewife 2 weeks 04.03.2016 02.04.2016 30 Good 
18. 21913 Ganesan 45/M Driver 1 Year 06.03.2016 04.04.2016 30 Good 
19. 21914 Subramanium 50/M Coolie 6 Months 06.03.2016 04.04.2016 30 Good 
20. 24459 Sundari 33/F Housewife 6 Months 15.03.2016 13.04.2016 30 Good 
 
 
 
2
II. CASE SUMMARY OF IN-PATIENTS 
 
S.No IP. No Name Age / Sex Occupation 
Duration of 
the illness 
Starting of 
Treatment 
End of 
Treatment 
No. of days Treated Results IP OP  Total 
1. 401 Pichammal 60/F Housewife 3 Months 16.02.2016 16.03.2016 30 - 30 Good 
2. 406 Jothi 23/F Coolie 1 Year 16.02.2016 23.02.2016 08 22 30 Good 
3. 478 Pappa 55/F Coolie 1 Year 23.02.2016 23.04.2016 30 - 30 Good 
4. 544 Gomathi 46/F Housewife 6 Months 29.02.2016 29.03.2016 30 - 30 Good 
5. 571 Shanmugakani 57/F Housewife 1Year 02.03.2016 31.03.2016 30 - 30 Good 
6. 611 Selvabackiyam 50/F Coolie 6 Months 07.03.2016 01.04.2016 26 4 30 Good 
7. 667 Subbu 55/F Coolie 1 Year 10.03.2016 06.04.2016 28 2 30 Good 
8. 736 Thaiaamal 57/F Housewife 3 Months 18.03.2016 29.03.2016 12 18 30 Good 
9. 953 Muthu 55/M Coolie 6 Months 07.04.2016 25.04.2016 14 16 30 Good 
10. 954 Ponnukutti 58/F Housewife 1 Year 07.04.2016 20.04.2016 14 16 30 Moderate 
11. 962 Sendu 60/F Coolie 6 Months 08.04.2016 22.04.2016 15 15 30 Moderate 
12. 964 Mookkammal 35/F Housewife 3 Months 08.04.2016 18.04.2016 11 19 30 Good 
13. 980 Pappa 55/F Coolie 1 Year 09.04.2016 28.04.2016 20 10 30 Good 
14. 983 Gurusamy 55/M Coolie 6 Months 09.04.2016 08.05.2016 30 - 30 Good 
15. 1000 Rathinammal 60/F Housewife 1 Year 13.04.2016 12.04.2016 30 - 30 Fair 
16. 1025 Varatharajan 50/M Farmer   6 Months 16.04.2016 26.04.2016 11  19 30 Fair 
17. 1070 Murugan 55/M Coolie 6 Months 21.04.2016 17.05.2016 27 3 30 Good 
18. 1105 Mohammed 52/M Coolie 4 Months 25.04.2016 24.05.2016 30 - 30 Moderate 
19. 1121 Subbammal 40/F Coolie 6 Months 27.04.2016 26.05.2016 30 - 30 Good 
20. 1148 Perumal 53/M Coolie 1 Year 29.04.2016 28.05.2016 30 - 30 Good 
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III. LABORATORY INVESTIGATION  REPORT  OF  THE  OUT PATIENTS 
S.
no OP  No Name 
Age / 
Sex 
Before treatment After Treatment ESR (mm) Blood 
Sugar  
®(gms/dl) 
Urine analysis Stools  
TC 
(cu/m
m 
DC TC 
(cu/m
m 
DC BT AT BT AT BT AT  
P
% 
L
% 
E
% 
P
% 
L
% 
E
% 
½ 
hr 
1 
hr 
½ 
hr 
1 
hr BT AT 
A
lb 
S
u
g 
Dep Alb 
S
u
g 
Dep 
O
v
a 
C
y
st 
O
v
a 
C
y
st 
O
B 
1 12963 Kalaivani 24 F 8000 66 31 3 9700 58 40 2 10 20 7 15 128 110 N N NAD N N NAD N N N N N 
2 12866 Janani 29 F 8700 59 37 4 9000 60 36 4 10 20 5 10 83 80 N N NAD N N NAD N N N N N 
3 13206 Sivaranjani 20 F 6100 64 34 2 7000 60 37 3 2 10 2 10 84 93 N N NAD N N NAD N N N N N 
4  13962 Shanthi 46 F 6300 63 32 5 7300 60 36 4 7 25 7 15 99 110 N N NAD N N NAD N N N N N 
5 13963 Pappathi 50 F 8000 60 40 5 8000 58 39 3 20 40 10 20 130 100 N N NAD N N NAD N N N N N 
6 14074 Kalyani 57 F 9100 59 38 3 9800 57 40 3 15 47 7 35 83 85 N N NAD N N NAD N N N N N 
7 15376 Rajeshwari 41 F 8700 59 39 2 8700 58 39 3 2 3 5 10 80 82 N N NAD N N NAD N N N N N 
8 15622 Maheshwari 43 F 9000 56 40 4 9200 59 39 2 10 20 6 12 80 90 N N NAD N N NAD N N N N N 
9 16301 Mary 52 F 8100 60 37 3 8700 59 38 3 10 22 5 15 135 120 N N NAD N N NAD N N N N N 
10 17775 Geetha 40 F 8400 65 32 3 9000 60 37 3 3 12 5 10 100 88 N N NAD N N NAD N N N N N 
11 18972 Murugan 42M 8800 63 35 2 9000 62 36 2 15 30 7 15 85 88 N N NAD N N NAD N N N N N 
12 19107 Anantham 60 F 9500 80 18 2 9700 77 20 3 10 20 5 10 76 85 N N NAD N N NAD N N N N N 
13 19538 Chelladurachi 50 F 7200 62 30 8 9100 60 38 2 10 20 6 12 115 120 N N NAD N N NAD N N N N N 
14 19597 Rekha 43 F 9100 58 39 3 9100 60 38 2 15 30 10 20 110 90 N N NAD N N NAD N N N N N 
15 20311 Gowdulaalam 60M 8000 58 36 6 8600 66 28 6 4 28 5 12 110 77 N N NAD N N NAD N N N N N 
16 20371 Jesuraj 54M 8000 60 36 4 8600 61 36 3 7 15 6 12 90 80 N N NAD N N NAD N N N N N 
17 21436 Leela 57 F 7500 66 30 4 8000 57 40 3 5 15 5 10 89 87 N N NAD N N NAD N N N N N 
18 21913 Ganesan 45M 7500 57 39 4 8100 58 40 2 4 16 5 10 80 83 N N NAD N N NAD N N N N N 
19 21914 Subramanium 50M 8100 54 43 3 8500 57 40 3 7 15 6 12 84 80 N N NAD N N NAD N N N N N 
20 24459 Sundari 33 F 8100 60 36 4 8500 60 36 4 10 20 7 15 88 85 N N NAD N N NAD N N N N N 
BT – Before Treatment, AT – After Treatment, N – Nil  TC – Total Blood Count, DC – Differential Blood Count, P – Polymorphs, L – Leucocytes ,E-Eosinophils 
ESR – Erythrocytes Sedimentation Rate, Alb – Albumin, Sug – Sugar, Dep– Deposits, OB – Occult blood 
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                                                     IV. LABORATORY INVESTIGATION REPORT OF THE IN PATIENTS 
S.
no 
IP  
No 
Name Age / 
Sex 
Before treatment After Treatment ESR (mm) Blood 
Sugar  
®(gms/dl) 
Urine analysis Stools  
TC 
(cu/m 
DC TC 
(cu/m
m 
DC BT AT BT AT    
P
% 
L
% 
E
% 
P
% 
L
% 
E
% 
½ 
hr 
1 
hr 
½ 
hr 
1 
hr 
BT AT A
lb 
S
u
g 
Dep A
lb 
S
u
g 
Dep O
v
a 
C
y
st 
O
v
a 
C
y
st 
O
B 
1 401 Pichammal 60/F 8500 58 39 3 9100 58 39 3 10 20 6 12 110 90 N N NAD N N NAD N N N N N 
2 406 Jothi 23/F 9100 59 38 3 9600 58 40 2 10 20 5 10 90 88 N N NAD N N NAD N N N N N 
3 478 Pappa 55/F 8400 57 39 4 9000 58 39 3 7 15 5 10 88 86 N N NAD N N NAD N N N N N 
4 544 Gomathi 46/F 8100 60 37 3 8500 60 38 2 5 12 5 10 90 88 N N NAD N N NAD N N N N N 
5 571 Shanmugakani 57/F 7800 60 36 4 8300 59 39 2 7 15 5 15 100 90 N N FPC N N FPC N N N N N 
6 611 Selvabackiyam 50/F 8400 53 44 3 8800 53 45 2 5 12 5 10 90 88 N N NAD N N NAD N N N N N 
7 667 Subbu 55/F 9000 60 38 2 9100 60 38 2 5 10 5 10 88 90 N N NAD N N NAD N N N N N 
8 736 Thaiaamal 57/F 8300 59 38 3 8200 60 37 3 10 20 5 10 85 90 N N NAD N N NAD N N N N N 
9 953 Muthu 55/M 8100 59 38 3 8500 59 39 2 7 15 5 15 83 80 N N NAD N N NAD N N N N N 
10 954 Ponnukutti 58/F 8700 58 39 3 8800 59 39 2 10 20 5 10 85 88 N N NAD N N NAD N N N N N 
11 962 Sendu 60/F 8500 57 40 3 8800 60 38 2 10 20 10 20 88 90 N N NAD N N NAD N N N N N 
12 964 Mookkammal 35/F 7800 59 38 3 8100 59 38 3 5 10 5 10 88 85 N N NAD N N NAD N N N N N 
13 980 Pappa 55/F 9600 59 38 3 9600 60 37 3 5 12 5 10 100 90 N N NAD N N NAD N N N N N 
14 983 Gurusamy 55/M 7500 59 37 4 8600 59 39 2 2 5 5 10 83 80 N N NAD N N NAD N N N N N 
15 1000 Rathinammal 60/F 7500 59 38 3 7500 59 38 3 10 22 7 15 90 85 N N NAD N N NAD N N N N N 
16 1025 Varatharajan 50/M 8100 59 39 2 8300 59 39 2 5 10 7 15 85 87 N N NAD N N NAD N N N N N 
17 1070 Murugan 55/M 7600 59 38 3 7700 59 38 3 6 20 5 10 88 86 N N NAD N N NAD N N N N N 
18 1105 Mohammed 52/M 8000 60 38 2 8100 59 38 3 12 20 5 10 93 90 N N NAD N N NAD N N N N N 
19 1121 Subbammal 40/F 9000 59 38 3 9100 60 37 3 10 20 7 15 90 88 N N FPC N N FPC N N N N N 
20 1148 Perumal 53/M 7500 70 28 2 8100 60 37 3 20 45 10 20 86 88 N N NAD N N NAD N N N N N 
BT – Before Treatment, AT – After Treatment, N – NilTC – Total Blood Count, DC – Differential Blood Count, P – Polymorphs, L – Leucocytes, E – Eosinophils 
ESR – Erythrocytes Sedimentation Rate, mm – Millimeter , Sug-Sugar,Dep- Deposits, FPC – Few Pus cells, OB-Occult blood 
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BIOCHEMICAL   AND   HAEMATOLOGICAL   REPORTS OF THE OUTPATIENT 
S.No OP 
No 
Name Age / 
Sex 
Blood 
urea 
Serum 
Creatinine 
Hb(gms/dl) RBC 
(millions/cu.m
m) 
PCV 
(%) 
MCV 
(fl) 
MCH 
(pg) 
MCHC 
(%) 
PB
S 
 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1 12963 Kalaivani 24 F 22 21 0.6 0.7 9.4 12.4 3.6 3.8 25 35 69 92 26.1 36.4 37.6 35.4 HM HM 
2 12866 Janani 29 F 26 23 0.6 0.6 8.3 11.5 3.8 4.0 26.7 34 74.1 89.4 23 30.2 31 33.8 HM HM 
3 13206 Sivaranjani 20 F 30 28 0.5 0.6 9.6 12.6 3.9 4.0 28 36 80 90 27.4 35 34.2 35 HM NN 
4  13962 Shanthi 46 F 32 30 0.8 0.8 9.2 11.5 3.8 3.9 26 33 76.4 91.6 27 31.9 35.3 34.8 HM HM 
5 13963 Pappathi 50 F 30 27 0.6 0.7 9.1 12.5 3.9 4.0 26.3 36 75.1 94.7 26 32.8 34.6 34.7 HM NN 
6 14074 Kalyani 57 F 28 28 0.6 0.7 8.8 12 3.9 4.0 26 36 70.2 92 23.7 46 33.8 33.4 HM NN 
7 15376 Rajeshwari 41 F 24 23 0.8 0.6 7.8 11.6 3.9 4.2 29 38 82.8 90 22.2 36.2 26.8 41.4 HM NN 
8 15622 Maheshwari 43 F 22 23 0.7 0.6 7.1 10.2 3.9 3.9 28 34 75.6 97 19.1 29 25.3 30 HM HM 
9 16301 Mary 52 F 23 24 0.9 0.8 7 10.5 3.8 4.10 29 37 82.8 87 20 29 24.1 28.4 HM NN 
10 17775 Geetha 40 F 24 23 0.6 0.6 7.7 10.4 3.9 4.1 30 38 85.7 95.5 22 28.8 25.7 27.4 HM NN 
11 18972 Murugan 42M 27 27 0.6 0.6 9.4 12.7 4.01 4.1 26.3 36 77.3 90 27.6 35.2 35.7 35.2 HM NN 
12 19107 Anantham 60 F 28 24 0.7 0.6 9.8 11.8 3.91 4.22 32.2 40 89.4 95.2 27 31 30.4 29.5 HM HM 
13 19538 Chelladurachi 50 F 27 25 0.8 0.8 9.9 12.4 4.0 4.1 29 35 80 92 30.9 36.4 34.1 35.4 HM HM 
14 19597 Rekha 43 F 35 30 0.7 0.6 7 8.2 3.9 4.0 25 28 73.5 77.8 20.5 22.7 28 29.2 HM NN 
15 20311 Gowdulaalam 60M 28 24 0.6 0.6 9.4 12.6 3.7 4.2 32 39 86.4 92.8 25.4 30 29.4 32.3 HM NN 
16 20371 Jesuraj 54M 22 23 0.6 0.6 9.8 11.5 3.5 3.8 30.2 29 82.8 97.3 28 30.2 33.7 31 HM NN 
17 21436 Leela 57 F 23 24 0.7 0.6 9.5 12.5 3.3 3.6 34.7 32 86.9 95.5 28.7 34.7 29.6 32.8 HM NN 
18 21913 Ganesan 45M 24 23 0.6 0.7 8.5 12 3.6 4.2 28.5 30 83.4 88.1 23.6 28.5 28.3 32.4 HM NN 
19 21914 Subramanium 50M 22 23 0.8 0.7 8 11.6 3.5 4.8 24.1 28 80 70.1 22.8 24.1 28.5 34.1 HM NN 
20 24459 Sundari 33 F 27 24 0.6 0.6 8.3 11.5 3.3 3.6 28 37 84.8 92.7 25.1 31.9 29.6 31 HM NN 
BT-BeforeTreatment , RBC-Red  Blood  Cells,PCV-Packed Cell Volume, MCV-Mean  Corpuscular  Volume, MCH-Mean  Corpuscular Haemoglobin, MCHC-Mean  
Corpuscular  Haemoglobin  Concentration, PBS-Peripheral  Blood  Smear, HM-Hypochromic  Microcytic, NN-Normochromic Normocytic 
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BIO CHEMICAL  AND HAEMATOLOGICAL  REPORTS OF THE IN PATIENT 
 
 
S.No OP 
No 
Name Age / 
Sex 
Blood 
urea 
Serum 
Creatinine 
Hb(gms/dl) RBC 
(millions/cu.
mm) 
PCV 
(%) 
MCV 
(fl) 
MCH 
(pg) 
MCHC 
(%) 
PBS 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1 401 Pichammal 60/F 30 27 0.6 0.7 8 11.6 3.5 3.2 28 34 80 96.2 22.8 36.2 28.5 34.1 HM HM 
2 406 Jothi 23/F 28 27 0.6 0.6 9 12.1 3.4 3.3 31 38 81.1 85.1 26.4 36.7 29.1 31.8 HM NN 
3 478 Pappa 55/F 27 27 0.8 0.7 9.6 12 3.6 3.8 30 37 83.3 97.3 26.7 31.5 32 32.4 HM NN 
4 544 Gomathi 46/F 26 24 0.7 0.6 8.8 11.8 3.4 3.6 30 37 88.2 92.7 25.8 32.7 29.3 31.8 HM NN 
5 571 Shanmugakani 57/F 28 27 0.8 0.7 9.2 12.2 3.2 4.0 28 37 87.5 92.5 28.7 30.5 32.8 32.9 HM NN 
6 611 Selvabackiyam 50/F 27 23 0.6 0.6 9 12.5 3.7 3.5 32 38 86.4 98.5 24.3 35.7 28.1 32.8 HM NN 
7 667 Subbu 55/F 26 25 0.8 0.7 8.4 11.5 3.8 3.6 29 37 76.3 92.7 22.1 31.9 28.9 31.1 HM NN 
8 736 Thaiaamal 57/F 24 23 0.6 0.7 8.6 11.6 3.2 3.6 29 37 80.6 92.7 26.2 32.2 29.6 31.3 HM NN 
9 953 Muthu 55/M 24 23 0.6 0.8 9.8 12 3.5 3.8 31 38 88.5 96 28 31.5 31.6 31.5 HM HM 
10 954 Ponnukutti 58/F 26 23 0.6 0.6 8 10.2 2.8 3.4 28 35 80 92.9 28.5 30 28.5 29.1 HM NN 
11 962 Sendu 60/F 27 28 0.6 0.6 9.3 11.5 2.7 3.8 29 37 87.4 97.3 34.4 30.2 32.1 31.1 HM HM 
12 964 Mookkammal 35/F 27 24 0.6 0.7 8.4 11.5 3.8 4.2 28.3 37 74.4 88.1 22.1 27.3 29.6 31.1 HM NN 
13 980 Pappa 55/F 28 26 0.8 0.6 8.5 11.1 3.6 3.4 28 35 77.7 92.9 23.6 32.6 30.3 31.7 HM NN 
14 983 Gurusamy 55/M 21 23 0.6 0.6 8.8 11.8 3.5 4.2 30 38 85.7 90.4 25.1 28.1 29.3 31.1 HM HM 
15 1000 Rathinammal 60/F 27 25 0.8 0.7 9.2 10.5 3.6 3.8 31 38 86.1 96 25.6 27.6 29.6 27.6 HM NN 
16 1025 Varatharajan 50/M 23 22 0.7 0.6 7.6 8.7 3.4 4.2 27 30 79.4 71.4 22.3 20.7 28.1 29 HM NN 
17 1070 Murugan 55/M 24 22 0.6 0.6 8.5 11.5 3.2 4.2 29 37 90.6 88.1 26.5 27.3 29.3 31.1 HM NN 
18 1105 Mohammed 52/M 26 25 0.9 0.6 8.4 10.5 3.5 3.8 29 37 82.8 97.3 24 27.6 28.9 28.3 HM HM 
19 1121 Subbammal 40/F 28 24 0.8 0.8 7.2 10.5 3.6 3.8 26 35 72.2 92.1 20 27.6 27.6 30 HM NN 
20 1148 Perumal 53/M 28 27 0.7 0.6 9.1 12.5 3.8 4.2 28.3 37 90 98.3 22.1 27.3 28.4 32.1 HM NN 
BT-BeforeTreatment , AT-After Treatment ,RBC-Red  Blood  Cells,PCV-Packed Cell Volume, MCV-Mean  Corpuscular  Volume, MCH-Mean  Corpuscular Haemoglobin, 
MCHC-Mean  Corpuscular  Haemoglobin  Concentration, PBS-Peripheral  Blood  Smear, HM-Hypochromic  Microcytic, NN-Normochromic Normocytic  
1DISCUSSION
           Untreated Vatha pandu noi produces many complications.The symptoms of
VathaPandu are closely related to Iron deficiency Anaemia.
Totally 40 patients were selected 20 patients were treated in OPD and 20 patients
were treated in IPD of  PG Pothumaruthuvam Department, Government Siddha medical
College and Hospital, Palayamkottai. All the patients were administered with a trial
drug “Karisalankanni chooranam”. The time duration of treatment was 30 days and
all necessary investigations were carried out to all patients and followed up regularly
in the OP & IP department.
Sex:
Among 40 cases, 29 Patients (72.5%) were females and 11 Patients(27.5%)
were males.
Although Vathapandu affects both sexes. Females are mostly affected than
males. This may be due to excessive menstrual blood loss which aggregates the already
existing malnutrition.
Age:
Out of 40 patients, 21 Patients(52.5%) were in the age group of 51-60,  12
Patients(30%) were in the age group of  41-50,  3 Patients(7.5% ) were in the age
group of 31- 40, 3 Patients (7.5%)were in the age group of 21-30, 1 Patient (2.5%)
were in the age group of  12-20.
2Kaalam:
Out of 40 patients, 5 Patients(12.5%) comes under VathaKaalam and 35
Patients(87.5%) comes under PithaKaalam.
Paruvakaalam:
              Out of 40 patients, 22 Patients(55%) comes under Pinpani, 11 patients (27.5%)
come under Elavenil, and 7 Patients(17.5%) comes under Munpani kaalam.
.Thinai:
Out of 40 patients, 35 Patients(87.5%) comes under Marutham and  3 patients
(7.5%) comes under Neithal, 2 patients(5%) comes under mullai nilam.
 Occupation:
Out of 40 patients, 21 Patients(52.5%) were House wife, 12 Patients(30%)
were Labours, 4 (10%)were office going and remaining 3 Patients(7.5%) are
students.labours  were  more  affected  due  to  malnourished  diet.
Socio-economical status:
           Out of 40 patients, 33 Patients(82.5%) belongs to low income group , 7
Patients(17.5%)   belongs  to  middle income  group. Economically  low  income
group  were   more  affected  than  middle or  high  income group.
Diet:
Out of 40 patients, 31 Patients (77.5%) were mixed diet and 9 Patients (22.5%)
were vegetarian.
3Aetiological factors:
Out of 40 patients, 37 patients(92.5%) were  due to  nutritional  deficiency,3
patients(7.5%) were due to blood loss. So it is evident  that  nutritional  deficiency
plays  a  major  role in  causing  Iron deficiency Anaemia.
Mukkutram:
Vatham:
 Pranan was affected in all the patients 100%   reflected as dyspnoea  on exertion.
 Abanan was affected in 11 patients (27.5%) reflected as constipation and
menorrhagia.
 Viyanan was affected in 35 patients (87.5%)  reflected  as  headache and joint
pain.
 Samanan was affected in all patients 100% reflected as loss of appetite.
 Kirugaran was  affected in  all patients  100%  reflected  as  loss of  appetite  and
Devathathan   was  affected in  all  patients 100%  resulting  in  fatigue.
Pitham:
 Analagam was affected in all patients (100%) producing loss of appetite.
 Ranjagam was affected in all patients (100%) resulting in pallor of conjunctiva
and nail bed.
4 Sathagam was  affected in  all  patients (100%)  and  Pirasagam  was  affected  in
18 patients(45%)  resulting  in   pallor of  skin (Hb  below 8gms/dl).
Kabham:
 Avalambagam was affected in all patients (100%) resulting in dyspnoea on
exertion.
 Kilethagam was affected in all patients (100%) resulting in loss of appetite.
 Santhigam was affected in 14 cases (35%) resulting pain in knee joints.
Ezhu udal thathukkal:
 Saaram was affected in all patients (100%) causing tiredness.
 Senneer was affected in all patients (100%) producing pallor of conjunctiva and
nail bed.
 Enbu was affected in 5 patients (12.5%) causing joint pain.
Ennvagai thervugal:
 All patients Naa, Niram and Vizhi were affected reflected as pallor of conjunctiva
and nailbed.
 Malam was affected in 11 patients (27.5%)  due to constipation.
5Naadi:
 30 of cases (75%) had Vatha Kapha Naadi, and 10 of cases (25%)  had Kabha
Pitha Naadi .
Neikuri:
 Out of 40 patients, 22 patients (55%) had Vatha Neer, 12 patients (30%) had
Kabha Neer and 6 patients( 15%) had  Pitha Neer Neikuri.
Investigations:
            TC, DC, ESR, Hb, PCV,MCV,MCH,MCHC,Peripheral blood smear, Blood sugar,
Blood urea ,Serum creatinine and routine  urine and motion test  were  taken  and
recorded before and  after treatment.
Clinical Study:
          All the patients were treated with Karisalankanni chooranam for an average
of 30 days. Blood and urine was tested after the completion of treatment.
Clinical symptoms:
           Out of 40 patients, 40 patients (100%) had Pallor  of conjunctiva  and  nail bed,
Fatigue, Loss of  appetite, Dyspnoea on exertion, 29 Patients (72.5%) had Headache,
6 patients (15%)  had  Glossitis, 11patients (27.5%) had Constipation, 18 patients
(45%) had Giddiness  and  Tachycardia.
6Clinical Prognosis:
             After 30 days  of  treatment   Pallor of conjunctiva  and nail  bed ,Loss  of
appetite  and  Fatigueness  present in 2 patients (5%),  Dyspnoea on exertion  present
in 5 patients(12.5%),Headache present in 4 patients (10%), Glossitis present in 1
patient(2.5%).
Haemoglobin level:
           After treatment 31 patients(77.5%)  show increase  in Hb 3gms/dl and above, 6
patients(15%)  show  increased in  Hb 2 - 3gms/dl  and  3 patients(7.5%)  show
increased in 1gm/dl.
Trial medicine:
 Karisalankanni chooranam was administered 2gm BD with sugar in hot water
after food for 30 days.
 This drug stimulates appetite due to the presence of Chukku, Vitamin C is essential
for iron absorption presence of Thiribala in the trial medicine it enhance the
absorption.
 Usually oral iron therapy induces constipation, but this trial drug did not produce
constipation   as it contains thiribala which act as a laxative.
7Grading of results:
Among 40 patients, 31 cases (77.5%) showed good result, 6 cases (15%) showed
moderate  result, 3 cases (7.5%)  showed poor result.
SUMMARY
The “Vathapandu Noi’’, a type of clinical condition with wide constitutional
features was taken for this study.
The consummate literary collections from various siddhars has clearly mentioned
the etiological factors, classifications of the disease and symptoms, complications,diet
etc., according to their views.
The efficacy of the medicine “Karisalankanni chooranam” was studied and
observed during this research work.
“Pandu” an ancient clinical entity with its historical importance correlated to
the modern clinical entity “Anemia”. Anemia in every aspects of “Vathapandu Noi’’
with symptoms of pallor, anorexia, abdominal pain, indigestion, lasstitude, palpitation
are noted with the clinical features discussed in modern medical text books.
The feasibility of considering “Vatha pandu” as “Iron Deficiency Anemia” is
observed after considering the Siddha etiological factors which coincides to the modern
aspects.
8In this study 20 patients of both sexes of different age groups with classical
clinical symptoms were selected as inpatients and another 20 patients were taken as
out patients in post graduate department of Maruthuvam, Government Siddha Medical
College and Hospital, Palayamkottai.
            A total of 40 patients were treated in the OPD & IPD. The  clinical and
pathological  assessment  was  carried  out  on  the  basis of both  Siddha  and  modern
aspects.
            All the 40 patients were treated with Karisalankanni chooranam (2 gm/bd
dailywith sugar in hotwater). The duration of the treatment was fixed as 30 days. The
responses were assessed and recorded.
It’ll be seen that well balanced diet is essential for overcoming this disease.
Proper care food, manner and environment in which it is produced is of great
importance in the preservation of good health.
Socio-economical status plays an important role in this aliment. The poor
peoples are unhygeine with the usage of contaminated food and water, who were more
prone to worm infestation.
The trial medicine is easily totarable by patients without any untoward effects
and the medicine is very cheap.
Bio-chemical and pharmacological analysis reveal that the test medicine has
significant haematinic effects.
9CONCLUSION
The dissertation medicine “Karisalankanni chooranam” is the potent drug for
the remedy of Iron Deficiency Anemia.
Research finding shows that 80% of the inpatients was improved well and 15%
of the inpatients was moderately improved and 5% of the inpatients were poorly
improved. 75 % of the outpatients was improved well and 15% of the outpatients was
moderately improved and10 % of the outpatients was poorly improved.
The trial medicine was very effective to the patients and there was no recurrence
of symptoms. The trial medicine is pure herbal formulation and it is free from side
effects, so they are useful for long term purpose.
If the man strictly adheres to the Siddha’s principle he will lead a healthy and
happy life.Out of 40 patients, 31 cases (77.5%) show good result, 6 cases (15%)
show   moderate  result, 3 cases(7.5%)  show  mild result.
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SUMMARY
The “Vathapandu” noi, a type of clinical condition with wide constitutional
features was taken for this study.
The consummate literary collections from various siddhars has clearly mentioned
the etiological factors, classifications of the disease and symptoms, complications,diet
etc., according to their views.
The efficacy of the medicine “Karisalankanni chooranam” was studied and
observed during research.
“Pandu” an ancient clinical entity with its historical importance correlated to
the modern clinical entity “Anemia”. Anemia in every aspects of “Vathapandu noi”
with symptoms of pallor, anorexia, abdominal pain, indigestion, lasstitude, palpitation
are noted with the clinical features discussed in modern medical text book.
The feasibility of considering “Vatha pandu” as “Iron Deficiency Anemia” is
observed after considering the Siddha etiological factors which coincides to the modern
aspects.
In this study 20 patients of both sexes of different age groups with classical
clinical symptoms were selected as inpatients and another 20 patients were taken as
out patients in post graduate department of Maruthuvam, Government Siddha Medical
College and Hospital, Palayamkottai.
11
            A total of 40 patients were treated in the OPD & IPD. The  clinical and
pathological  assessment  was  carried  out  on  the  basis of both  Siddha  and  modern
aspects.
            All the 40 patients were treated with Karisalankanni chooranam (2 gm/bd
dailywith sugar in hotwater). The duration of the treatment was fixed as 30 days. The
responses were assessed and recorded.
It’ll be seen that well balanced diet is essential for overcoming this disease.
Proper care food, manner and environment in which it is produced is of great
importance in the preservation of good health.
Socio-economical status plays an important role in this disease.
The trial medicine is easily tolarable by the patients without any side effects and
the medicine is low cost.
Bio-chemical and pharmacological analysis revealed that the trial medicine
has significant haematinic effects.
12
CONCLUSION
The open randamised clinical trial on medicine “Karisalankanni chooranam”
is the highly potential drug for the remedy of Iron Deficiency Anemia.
Research finding showed that 80% of the inpatients was improved well and 15%
of the inpatients was moderately improved and 5% of the inpatients were poorly
improved. 75 % of the outpatients was improved well and 15% of the outpatients was
moderately improved and10 % of the outpatients was poorly improved.
The trial medicine was very effective  to Anaemia patients. The trial medicine is
purely herbal formulation and it is free from side effects.
If the man strictly adheres to the Siddha’s principle he will lead a healthy and
happy life.
ANNUXURE IV 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL ON  
VATHA PAANDU (IRON DEFICIENCY ANAEMIA) WITH KARISALANKANNI 
CHOORANAM. 
FORM-I 
(SCREENING AND SELECTION PROFORMA) 
1.Name___________                     2.Age_____   3.gender________  4.Phone no  _________ 
5. OP No. 6. IP No. 7. S.No.  . 
 INCLUSION CRITERIA:  
 Age :18- 60Yrs 
 Sex : Both male and female 
 Hb level between 7.1 – 10 grams%. 
 Pallor of skin, mucous membrane, conjunctiva, nail beds. 
 Fatigueness, shortness of breath, palpitation. 
 Anorexia. 
 Smear showing hypochromic microcytic. 
 Worm infestation. 
 Patients who are willing for admission and stay in IPD for 30days or willing to attend 
OPD 
 Patients who are willing to give blood for laboratory investigation. 
 Patient willing to sign the informed consent stating that he/she will consciously  stick 
to the treatment during 30 days.  
 
EXCLUSION CRITERIA 
 Hb less than 7. 
 Congenital heart disease. 
 Patient with chronic renal disease. 
 Liver disease. 
 Inherited defects. 
 Haemorrahagic disorders. 
 Thalassemia. 
 Ischaemic heart disease. 
 Thyroid disorder. 
 Diabetes mellitus. 
 
DATE  : 
STATION :      SIGNATURE OF  HOD 
 
 SIGNATURE OF INVESTIGATOR                                 SIGNATURE OF LECTURER 
 
 
 
 
 
 
 
 
 
 
 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL ON   
VATHA PAANDU(IRON DEFICIENCY ANAEMIA) WITH KARISALANKANNI 
CHOORANAM. 
FORM l A     
    
HISTORY PROFORMA ON ENROLLMENT 
 
1. Serial No of the case:   _______________                           2. OP/IP No:_________ 
 
       
3. Name: ________________               4. Gender:  Male                     Female    
 
 
5. Age (years): _________   DOB            
      Date       Month            Year 
 
6.Address: -------------------------------------- 
                     -------------------------------------- 
                     -------------------------------------- 
 
7.A.Occupation:    -----------------------------                         B. Nature of work----------------- 
 
 
8. Educational  Status:   A) Illiterate                  B)Literate          
 
 
9.Height:---------- cms                10.Weight:----------kg 
 
11. Complaints and Duration:   
________________________________________________________________________ 
 
_______________________________________________________________________ 
 
________________________________________________________________________ 
12. Past History                     
 hypertension    ______________        
diabetes mellitus ______________        
asthma   ______________        
pt   ______________ 
 
HABITS 
    
A) Smoking  : 1. Yes                 duration ________ years;    Number - _____     2. No  
 
B) Alcoholism:1. Yes                duration ________ years;    Quantity- ____ ml 2. No  
 
C) Tobacco chewing:  1. Yes                duration ________ years                          2.No 
                                     
D) Betel chewing     :  1. Yes                duration ________ years                          2.No 
 
 
13.Dietary style:   A.Pure vegetarian                B.Non-vegetarian                C. Mixed diet 
 
14. Drug history: Had the patient been treated before with allopathy drug?  
 
                                A) Yes                                    2) No                                     
 
15 Marital status :   1.Married         2.Unmarried                                                  
 
16. Family history : 
 
      Whether this problem runs in family?             1. Yes                               2.No   
  
       If yes, mention the relationship of affected person(s)  - ___________________________   
  
17. Menstrual history :                                                                                                                
 
 18. Bowel habits & micturition:      Normal  
 
            History of habitual constipation              1.Yes                      2.No                                                       
 
            History of frequent diarrhoea                  1.Yes                      2.No                                                         
 
            History of frequent dysuria                     1.Yes                      2.No                
 
 
19. Psychological state:      Normal                    Anxiety                   Depression             
 
  Date    :   
   
  Station   : 
 
  Signature of the Investigator: 
 
 
  Signature of the Lecturer :                                                           Signature of the HOD 
                                                              
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL  
VATHA PAANDU(IRON DEFICIENCY ANAEMIA) WITH KARISALANKANNI 
CHOORANAM. 
FORM II & II-A 
 
CLINICAL ASSESSMENT ON ENROLLMENT AND ON VISITS 
 
1. S.NO:  _______                                             2. OP/IP NO : __________                            
      3.  Name : _______________________              4. Gender      : __________    
      5. Date of assessment : _____________  
                       
 SIDDHA SYSTEM OF EXAMINATION 
1. ENVAGAI THERVU: [EIGHT-FOLD EXAMINATION] 
 I. NAADI: [PULSE PERCEPTION] 
      
   0stDay 
 
  07thDay 
  
  15th Day 
        
 21st Day  
 
 28th Day 
 
 30th Day 
Vali       
Azhal       
Iyyam       
Vali Azhal       
Azhal vali       
Iyya vali       
Vali Iyyam       
Azhal Iyyam       
 Iyya Azhal       
II. NAA:[TONGUE] 
 
 
  0th Day 07th Day  14th Day   21st Day 28th Day 30th Day 
Colour Dark/         
Yellow/ 
Red/       
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Taste Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Coating Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Fissure Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Saliva Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Dryness Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Glossitis Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Baldness Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
III.NIRAM: [COMPLEXION]    
0th 
Day 
07th day 14th Day 21st Day 28th Day 30th day 
Dark/ 
Yello
w/ 
tinted/ 
Pale 
Dark/ 
Yellow/ 
tinted/ 
Pale 
Dark/ 
Yellow/ 
tinted/ 
Pale 
Dark/ 
Yellow/ 
tinted / 
Pale 
Dark/ 
Yellow/ 
tinted/ 
Pale 
Dark/ 
Yellow/ 
tinted/ 
Pale 
 
IV.MOZHI: [VOICE] 
 
 
 
 
V.VIZHI: [EYES] (Lower palpabrel conjunctiva)   
    
 
 
 
 
VI. MALAM; [BOWEL HABITS / STOOLS] 
0th Day  07th day 14th Day 21st Day 28th Day 30th day 
Medium/ 
High/ 
Low / 
Pitched 
Medium/ 
High/ 
Low/ 
Pitched 
Medium/ 
High/ 
Low/ 
pitched 
Medium/ 
High/ 
Low/ 
pitched 
Medium/ 
High/ 
Low/ 
pitched 
Medium/ 
High/ 
Low/ 
pitched 
0th Day  07th day 14th Day 21st Day 28th Day 30th day 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ Pale 
 0th Day 07th Day 14th Day  21stDay 28th Day 30th day 
Colour Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ Pale 
Dark/ 
Yellow/ 
Red/ Pale 
 Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Consistency Solid/ 
Semisol
Solid/ 
Semisoli
Solid/ 
Semisoli
Solid/ 
Semisoli
Solid/ 
Semisoli
Solid/ 
Semisoli
  
 
 
 
 
 
 
 
 
VII. URINE EXAMINATION: 
 
id/ 
Watery 
d/ 
Watery 
d/ 
Watery 
d/ 
Watery 
d/ 
Watery 
d/ 
Watery 
Stool  bulk                         Normal
/ 
Reduce
d 
 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Constipation  Present/ 
Absent 
 
Present/ 
Absent 
 
Present/ 
Absent 
 
Present/ 
Absent 
 
Present/ 
Absent 
 
Present/ 
Absent 
 
Diarrhoea Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
NEERKURI 0th Day  07th day 14th Day 21st Day 28th Day  30th Day 
Niram 
[Colour]   
White/ 
Yellowi
sh/ 
Straw 
coloured
/ 
Crystal 
clear 
White/ 
Yellowis
h/Straw 
Coloured
/ 
Crystal 
clear 
White/ 
Yellowis
h/ 
Straw  
coloured/ 
Crystal 
clear 
White/ 
Yellowis
h/ 
Straw  
coloured/ 
Crystal 
clear 
White/ 
Yellowis
h/ 
Straw  
coloured/ 
Crystal 
clear 
White/ 
Yellowish
/ 
Straw  
coloured/ 
Crystal 
clear 
Manam 
[Odour] 
Present/  
Absent 
 Present/  
Absent 
Present/  
Absent 
Present/  
Absent 
Present/  
Absent 
Present/  
Absent 
Nurai 
[Froth] 
Nil/ 
Reduced
/ 
Increase
d 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Edai 
[Sp.gravity]                               
Normal/ 
Increase
d/ 
Normal/ 
Increased
/Reduced 
Normal/ 
Increased
/Reduced 
Normal/ 
Increased
/ 
Normal/ 
Increased
/ 
Normal/ 
Increased/ 
Reduced 
  
 
 
NEIKURI 0th Day  7th day 14th Day 21st Day 28th Day  30th Day 
Serpentine fashion       
Annular/Ringed 
fashion 
      
Pearl beaded fashion         
Mixed fashion       
Other fashion       
 
VIII. SPARISAM: [PALPATORY  PERCEPTION] 
0th Day  7th day 14th Day 21st Day 28thDay 30th day 
Warmth/ 
Cold/ 
 Sweat 
Warmth/ 
Cold/ 
Sweat 
Warmth/ 
 Cold/ 
Sweat 
Warmth/ 
Cold/ 
Sweat 
Warmth/ 
Cold/ 
Sweat 
Warmth/ 
Cold/ 
Sweat 
 
5. THEGI: [ TYPE OF BODY CONSTITUTION]    
Vatham predominant  Kabam predominant  
Pitham predominant  Thondha udal  
Reduced Reduced Reduced 
Enjal 
[Deposits] 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Volume   Normal/ 
Increase
d/ 
Reduced 
Normal/ 
Increased
/Reduced 
Normal/ 
Increased
/Reduced 
Normal/ 
Increased
/ 
Reduced 
Normal/ 
Increased
/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
 6.NILAM: [ LAND WHERE PATIENT LIVED MOST] 
  Kurinji                     Mullai                   Marutham                    Neithal                  Palai 
(Hilly terrain)           (Forest range)        (Plains)                     (Coastal belt)        (Arid regions)  
 7. KAALAM: 
Kaarkalam -                                  Pinpanikalam  -    
Koothirkalam -                             Ilavenil - 
Munpanikalam  -                          Muthuvenil - 
8. GUNAM: 
Sathuvam   -                      Rasatham -                         Thamasam  - 
 
9.IMPORIGAL (SENSORY ORGANS): 
 
 
 
 
  0th Day  7th day  14th Day  21st Day  28th Day   30th Day 
Mei  
(Skin) 
      
Vai 
(Buccal Cavity) 
      
Kann 
(Eye) 
      
Sevi 
(Ear) 
      
Mooku 
(Nose) 
      
10. KANMENDRIYAM ( MOTOR ORGANS) 
 
11.KOSANGAL(Sheath)   
 0th Day  7th day 14th Day  21st Day 28th Day 30th Day 
Annamaya  
Kosam 
      
Pranamaya kosam        
Manomaya 
kosam  
      
Vignanamaya 
kosam  
      
Ananthamaya 
kosam  
      
 
 
 
 
 
 
 
 0th Day  7th day 14th Day 21st Day 28th Day 30th Day 
Kai (upper 
limb) 
      
Kaal (lower 
limbs ) 
      
Vai   (buccal 
cavity) 
      
Eruvaai 
(excretory 
organs) 
      
Karuvaai  
(reproductive 
organs) 
      
12. MUKKUTRAM:[AFFECTION OF THREE HUMORS] 
 
A)VATHAM: 
 0th Day  7th day 14th Day 21st Day 28th Day 30th Day 
Praanan       
Abaanan        
Viyaanan       
Udhaanan       
Samanan       
Naagan       
Koorman       
Kirukaran       
Devatha-than       
Dhanan-jeyan       
 
 
B) PITHAM:   
 0th Day  7th day 14th Day 21st Day 28th Day 30th Day 
Analpitham        
 Ranjagam       
Saathagam       
Praasagam       
Aalosagam       
 
 
C) KABHAM: 
 0th Day  7th day 14th Day 21st Day 28th Day 30th Day 
Avalambagam       
Kilaethagam       
Pothagam       
Tharpagam       
Santhigam       
 
1.SEVEN UDALTHATHUS: (7 SOMATIC COMPONENTS)  
 
 
 
 
 
 0th Day  7th day 14th Day 21st Day 28th Day 30th Day 
Saaram [Chyme]       
Senneer [Blood]       
Oon [Muscle]       
Kozhuppu [Fat]       
Enbu [Bones]       
Moolai [Bone 
marrow] 
      
Sukkilam or suronitham 
[Genital discharges] 
      
14. SYSTEMIC EXAMINATION: 
 0th Day  7th day 14th Day 21st Day   28th Day 30th Day 
Locomotor system       
 
Cardiovascular 
system 
 
 
     
 
Respiratory system    
 
 
     
Gastro intestinal 
system 
     
 
 
     
Central nervous 
system  
 
 
     
Urogenital system       
Endocrine system       
 
15. GENERAL EXAMINATION: 
 
 0th Day 7th Day  14th Day  21st Day 28th Day 30th Day 
Height (cms)       
Weight (kg)       
Temperature (F0)          
Pulse rate (per min)       
Heart rate (per min)       
Respiratory rate 
(per min) 
      
Blood pressure 
(mm/Hg) 
      
Pallor       
Jaundice       
Cyanosis       
Lymphadenopathy       
Pedal edema       
Clubbing       
Jugular vein 
pulsation 
      
 
Signs and symptoms: 
S.NO Assesment 0 th 
day 
7 th day 14 th day 21 st day 28 th 
day 
30 
th 
day 
1. Pallor of 
conjunctiva and 
nail bed 
      
2. Fatigue       
3. Loss of  appetite       
4. Dyspnoea on 
exertion 
      
5. Headache       
6. Constipation       
7. Glossitis       
8. Giddiness       
9. Tachycardia       
 
 
  
Date       :       
Station   : 
 
Signature of the Investigator: 
 
Signature of the Lecturer      :                                        Signature of the HOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI,TIRUNELVELI DISTRICT 
POST-GRADUATE DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL ON  
VATHA PAANDU(IRON DEFICIENCY ANAEMIA) WITH KARISALANKANNI 
CHOORANAM. 
FORM III-LABORATORY INVESTIGATIONS 
1 Sl.No  2 OP/IP No  
3 Bed No  4 Name  
5 Age  6 Gender  
 
I.BLOOD 
  Before Treatment After Treatment 
1 
 
TC (cells/mm)   
2 
 
DC (%)   
 a)Neutrophils  
 
 
 b)Lymphocytes  
 
 
 cMmonocytes  
 
 
 d)Eosinophils  
 
 
3 
 
ESR(mm)   
 a)1/2 hour  
 
 
 b)1 hour  
 
 
4 
 
Haemoglobin   
5 
 
Blood sugar   
6 
 
Blood urea   
7 
 
Serum creatinine   
8 
 
Serum cholesterol   
9 
 
PCV   
10 
 
MCV   
11 
 
MCH   
12 
 
MCHC   
13 
 
TOTAL RBC   
14 
 
Platelet count   
15 Total iron binding capacity 
 
  
 
II.URINE 
 
  
 
Before Treatment After Treatment 
1 
 
Albumin 
 
  
2 Sugar 
 
  
3 Epithelial cells 
 
  
4 Pus cells 
 
  
5 Red blood cells 
 
  
6 Casts/Crystals 
 
  
 
 
 
Date       :       
Station   : 
Signature of the Investigator: 
 
Signature of the Lecturer      :                                        Signature of the HOD 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL ON   
VATHA PAANDU (IRON DEFICIENCY ANAEMIA) WITH KARISALANKANNI 
CHOORANAM. 
CONSENT FORM-IV A 
Certificate by Investigator 
 I certify that I have disclosed all details about the study in the terms readily understood by the 
patient. 
Date: ……………..      Signature: …………………………. 
  Name: …………………………….. 
Consent by Patient 
              I have been informed to my satisfaction, by the attending physician, the purpose of the clinical 
trial, and the nature of drug treatment and follow-up including the laboratory investigations to be 
performed to monitor and safeguard my body functions. 
    I am aware of my right to opt out of the trial at any time during the course of the trial without 
having to give the reasons for doing so. 
      I, exercising my free power of choice, hereby give my consent to be included        
             As a subject in the clinical trial of KARISALANKANNI CHOORANAM for the 
management of VATHA PAANDU ( IRON DEFICIENCY ANAEMIA). 
Date: ………………..   Signature: ………………………………… 
Name: ……………………………………. 
Date: ……………….    Signature of Witness: ……………………. 
Name………….. …………………………   
Relationship:……………………………… 
 
murpdh; rpj;j kUj;Jtf; fy;Y}hp kw;Wk; kUj;Jtkid> 
ghisaq;Nfhl;il>   
gl;lNkw;gbg;G nghJ kUj;Jtj;Jiw. 
;thjghz;L Neha;f;F kUe;jhf fhpryhq;fz;zp #uzk; 
ghpfhpg;Gj;jpwidf; fz;lwpAk; kUj;Jt Ma;T. 
 
 
xg;Gjy; gbtk; 
Ma;thsuhy; rhd;wspf;fg;gl;lJ 
  ehd; ,e;j Ma;T Fwpj;j midj;J tpguq;fisAk; Nehahspf;F GhpAk; tifapy; 
vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;. 
 
Njjp :       ifnahg;gk; : 
,lk; :         ngah; :  
Nehahspapd; xg;Gjy; 
  vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk; kUe;jpd; jd;ik kw;Wk; kUj;Jt 
topKiwiag; gw;wpAk; njhlh;e;J vdJ cly; ,af;fj;ij fz;fhzpf;fTk;> mjidg; 
ghJfhf;fTk; gad;gLk; kUj;Jt Ma;Tf;$l ghpNrhjidfs; gw;wp jPUg;jp mspf;Fk; tifapy; 
Ma;T kUj;Jtuhy; tpsf;fpf; $wg;gl;lJ. 
  ehd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; $whky; vg;nghOJ Ntz;LkhdhYk; 
,e;j ma;tpypUe;J vd;id tpLtpj;Jf; nfhs;Sk; chpikia njhpe;jpUf;fpNwd;. 
  ehd; vd;Dila Rje;jpukhf Njh;T nra;Ak; chpikiaf; nfhz;L ‘thjghz;L Neha;f;F 
fhpryhq;fz;zp #uzk;” ghpfhpg;Gj;jpwidf; fz;lwpAk;  kUj;Jt Ma;tpw;F vd;id cl;gLj;j 
xg;Gjy; mspf;fpNwd;.  
 
Njjp :        ifnahg;gk;: 
,lk; :        ngah; :  
 
Njjp:       rhl;rpf;fhuh; ifnahg;gk; :  
,lk;:         ngah;:  
       cwTKiw :  
  
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL ON   
VATHA PAANDU(IRON DEFICIENCY ANAEMIA) WITH KARISALANKANNI 
CHOORANAM. 
FORM IV B 
WITHDRAWAL FORM 
Name: ________________________       OPD/ IPD number: __________ 
Age   : ________      
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Reasons for withdrawal: 
 Long absence at reporting       : Yes                 No 
 Irregular treatment        : Yes                 No 
 Shift of locality                                                   : Yes                 No 
 Increase in severity of symptoms                 : Yes                 No 
 Development of severe adverse drug reactions  : Yes                 No 
 Date    :      
Station :     
 SIGNATURE  OF  INVESTIGATOR                                             SIGNATURE  OF  HOD 
          
                      
 SIGNATURE  OF LECTURER 
 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
           PRECLINICAL AND PHASE-II RANDOMIZED OPEN CLINICAL STUDY ON               
VATHA PAANDU(IRON DEFICIENCY ANAEMIA) WITH KARISALANKANNI   
CHOORANAM. 
                                                                  FORM IV C 
PATIENT  INFORMATION SHEET 
 
 This disease is not contagious. 
 It is a  clinical syndrome occurs due to deficiency of Iron. 
 Many herbal and mineral siddha medicines are currently practiced by the siddha 
practioners for Anaemia. 
 The trial drug is prescribed only with evidence of siddha literature. 
 The trial drug is prepared at the Gunapadam lab of government siddha medical college & 
hospital, palayamkottai. under the direct supervision of teaching faculties of   
Maruthuvam and Gunapadam Dept. 
 
Details of the trial drug: 
             
1. KARISALANKANNI CHOORANAM: 
                 DOSAGE :  Two grams, two times after food  
                ADJUVANT : Sugar  
                Duration : 30 days . 
 
 Patients are advised to take green vegetables, greens , protein foods, fibre foods, iron rich 
foods like dates, fig. 
 Patients must walk 30-45 minutes per day 
  Patients are advised to avoid tamarind, betel chewing, tobacco , alcohol and smoking. 
               
 
 GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL ON  
VATHA PAAND(IRON DEFICIENCY ANAEMIA) WITH KARISALANKANNI 
CHOORANAM. 
FORM  IV  D 
ADVERSE DRUG REACTION FORM 
 
Name: ________________________       OPD/ IPD No : __________ 
Age: ________      
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Description of adverse reaction: _______________________________________________ 
_________________________________________________________________________ 
 
Date: 
Station:  
       
SIGNATURE  OF  INVESTIGATOR                                                SIGNATURE  OF   HOD 
          
                      
 
SIGNATURE  OF LECTURER 
 
  
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
 PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL ON   
VATHA PAANDU(IRON DEFICIENCY ANAEMIA) WITH KARISALANKANNI 
CHOORANAM. 
FORM IV –E 
                                               (DRUG COMPLIANCE FORM) 
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